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Abstract 
The growing global epidemic of human tuberculosis (TB) results in 8 million new cases 
of this disease and 2 million deaths annually. Control thereof will require greater insight 
into the biology of the causative organism, Mycobacterium tuberculosis, and into the 
pathogenesis of the disease. This will benefit the design of new vaccines and diagnostic 
assays which may reduce the degree of both disease transmission and progression. 
Animal models have played a vital role in the understanding of the aetiology, 
pathogenesis, and treatment of TB. Much of such insight has been obtained from 
experimental infection models, and the development of new vaccines, for example, is 
dependant on these. Nonetheless, studies utilising naturally occurring TB in animals, 
such as those which have investigated the use of interferon-gamma release assays 
(IGRA) for its diagnosis, have contributed substantially to the body of knowledge in 
this field. However, there are few such examples, and this study sought to identify and 
investigate naturally occuring animal TB in South Africa as an opportunity to gain 
further insight into this disease.     
During the course of this study, the dassie bacillus, a distinctly less virulent variant of 
M. tuberculosis, was isolated from a rock hyrax from the Western Cape Province of 
South Africa. This has provided new insight into the widespread occurrence of this 
organism in rock hyrax populations, and has given impetus to further exploring the 
nature of the difference in virulence between these pathogens.  
Also investigated was M. tuberculosis infection in dogs in contact with human TB 
patients. In so doing, the first reported case of canine TB in South Africa was described, 
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a novel canine IGRA was developed, and a high level of M. tuberculosis infection in 
these animals was identified. This supports human data reflecting high levels of 
transmission of this pathogen during the course of human disease. Additionally, the fact 
that infected companion animals may progress to disease and potentially act as a source 
of human infection was highlighted. However, an attempt to adapt a flow cytometric 
assay to study cell-mediated immune responses during canine TB revealed the 
limitations of such studies in species in which the immune system remains poorly 
characterised. 
The use of IGRAs to diagnose TB was further explored by adapting a human assay, the 
QuantiFERON-TB Gold (In-Tube Method), for use in non-human primates. These 
studies have shown that such an adaption allows for the sensitive detection of TB in 
baboons (Papio ursinus) and rhesus macaques (Macaca mulatta) and may be suitable 
for adaption for use in other species. However, they have also evidenced the limitation 
of this assay to specifically detect infection by M. tuberculosis. 
Finally, to contextualise the occurrence of the mycobacterial infections described 
above, and other similar examples, these have been reviewed as an opinion piece. 
Together, these investigations confirm that animal models will continue to make 
important contributions to the study of TB. More specifically, they highlight the 
opportunities that naturally occuring animal TB provides for the discovery of novel 
insights into this disease.      
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 Opsomming 
Die wêreldwye tuberkulose (TB) epidemie veroorsaak agt miljoen nuwe gevalle en 
twee miljoen sterftes jaarliks. Ingryping by die beheer hiervan vereis begrip van die 
biologie van die mikroörganisme Mycobacterium tuberculosis, die oorsaak van TB,  
asook van die patogenese van die siekte self. Hierdie kennis kan lei tot ontwerp van 
nuwe entstowwe en diagnostiese toetse wat gevolglik beide die oordrag- en vordering 
van die siekte mag bekamp. 
Dieremodelle speel lankal 'n rol in ons begrip van die etiologie-, patogenese- en 
behandeling van TB. Insig is grotendeels verkry vanaf eksperimentele infeksiemodelle, 
en ontwikkeling van entstowwe, onder andere, is afhanklik van soortgelyke modelle. 
Desnieteenstaande, studies wat natuurlike TB voorkoms in diere ondersoek, 
byvoorbeeld dié wat op die ontwikkeling van interferon-gamma vrystellingstoetse 
(IGVT) fokus, het merkwaardige bydrae gemaak tot kennis en begrip in hierdie 
studieveld. Daar is slegs enkele soortgelyke voorbeelde. Om hierdie rede is die huidige 
studie uitgevoer waarbinne natuulike diere-TB geïdentifiseer en ondersoek is in Suid-
Afrika om verdere kennis en insig te win aangaande TB.  
Die "dassie bacillus", bekend om beduidend minder virulent te wees as M. tuberculosis, 
is tydens hierdie studie geïsoleer vanuit 'n klipdassie (Procavia capensis) in die Wes-
Kaapse provinsie, Suid-Afrika. Insig in die wydverspreide voorkoms van hierdie 
organisme in klipdassie bevolkings is gevolglik verkry en verskaf momentum om die 
aard van verskil in virulensie tussen dié patogene te bestudeer. 
 vii 
 
Voorts is M. tuberculosis infeksie bestudeer in honde wat in kontak is met menslike TB 
pasiënte en word die eerste geval van honde TB dus in Suid-Afrika beskryf. In hierdie 
groep diere, is 'n hoë vlak van M. tuberculosis infeksie geïdentifiseer deur gebruik te 
maak van 'n nuut ontwikkelde IGVT vir die diagnose van honde TB. Gevolglik 
ondersteun dié studie bevindinge van menslike studies wat toon dat besondere hoë 
vlakke van M. tuberculosis oordrag voorkom gedurende die verloop van die siekte. 
Verder toon die studie dat geïnfekteerde troeteldiere 'n bron van menslike infeksie kan 
wees. 'n Poging om 'n vloeisitometriese toets te ontwikkel om die aard van 
selgefundeerde immuunreaksies te bestudeer in honde met TB toon die beperkings van 
dergelike studies in spesies waarin die immuunsisteem gebrekkig gekarakteriseer is. 
Die gebruik van IGVT'e in die diagnose van TB is verder ondersoek deur 'n menslike 
toets (QuantiFERON-TB Gold, In-Tube Method) aan te pas vir die gebruik van nie-
menslike primaat gevalle. Hierdie studies toon gevolglik dat so 'n aanpassing toepaslik 
is vir hoogs sensitiewe deteksie van TB in chacma bobbejane (Papio ursinus) en rhesus 
ape (Macaca mulatta), en mag ook aangepas word vir gebruik in ander spesies. Tog 
word die beperkings van hierdie toets om infeksie wat spesifiek deur M. tuberculosis 
veroorsaak uitgelig. 
Ter afsluiting word hierdie studie in konteks geplaas deur 'n oorsig te gee van 
bogenoemde- en soortgelyke gevalle van dierlike infeksie deur mikobakterieë in Suid-
Afrika. 
Hierdie studies bevestig dat dieremodelle steeds belangrike toevoegings maak tydens 
die bestudering van TB en lig veral die moontlikhede uit dat bestudering van natuulike 
TB in diere kan lei tot die ontdekking van nuwe insigte ten opsigte van die siekte self. 
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CHAPTER 1 
Introduction 
______________________________________________________________________ 
 
1.1 Early animal models of tuberculosis 
The disease tuberculosis (TB), classically typified by the “tubercle”, or inflammatory 
granuloma, occurs in a broad range of animal hosts. It is caused by a group of closely 
related mycobacterial strains, such as Mycobacterium tuberculosis and Mycobacterium 
bovis, known collectively as the Mycobacterium tuberculosis complex (MTC). The 
infectious nature of TB, and the fact that it could be transmitted between species, was 
first proven in 1865, when Villemin transmitted the disease from human autopsy 
material to a rabbit
12
. However, depending on the species of host, and causative 
organism, a wide variety of disease outcomes are observed following infection by 
members of the MTC. As a result, interest in the comparative susceptibility of host 
species to these pathogens dates back to the first description of M. tuberculosis by 
Robert Koch in 1882, who reported on TB in a number of naturally infected host 
species and a wide range of experimental animals
26,31
. Subsequently, mice, rats, guinea-
pigs and rabbits were established as common models for the study of the pathogenesis 
of this disease
26
. However, these species were regarded as generally susceptible to TB 
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and unusual examples of animal models of experimental infection, such as dogs, which 
were believed to be relatively resistant to TB, were periodically used
19,42
. 
A limited number of early studies examined comparative antibody responses during TB. 
In 1941 it was shown that following infection, rabbit strains which were relatively 
resistant to TB produced greater amounts of antibody, more rapidly, than more 
susceptible strains
36
. However, most early comparative studies focussed on differences 
in gross pathology, histopathology, and the rate of bacterial multiplication in the tissues 
of infected host species (or strains). In 1952, Lurie et al. compared the growth of M. 
tuberculosis, and the resulting pathology, in resistant and susceptible inbred rabbit 
strains, interpreting differences between the two as “all-or-nothing”35. In 1956, Francis 
compared the pathology induced in dogs, guinea pigs, rabbits and mice experimentally 
infected with M. tuberculosis or M. bovis and concluded that dogs exhibited a “native” 
resistance to the disease
19
. However, at these times, the limited insight into the specific 
mechanisms of the disease and almost non-existent tools for examining the immune 
response precluded a clearer understanding of the nature of these differences. Despite 
the development of more sophisticated experimental models, basic infection models are 
still utilised to examine the comparative susceptibility of various host species to 
disease. In 2002, infection experiments showed that racoons (Procyon lotor) were 
highly resistant to TB
50
, and that they and North American opossums (Didelphus 
virginiana)
16
 were unlikely to act as maintenance hosts of the disease in wildlife 
populations.  
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1.2 Elucidation of cell-mediated immunity to tuberculosis 
In the 1970s, it was shown that the adoptive transfer of thymus-dependant lymphocytes 
(T cells) from M. bovis Bacille Calmette-Guérin (BCG)-vaccinated rats and mice, to 
naïve conspecifics, conferred immunity to the host animals, while the transfer of serum 
between these, did not
33,34
. Subsequently, this cell-mediated immunity (CMI) received 
greater attention in attempts to understand the nature of TB immunity. The 
identification of antigenic markers on phenotypically distinct immune cells, the so-
called clusters of differentiation (CD) molecules, and the production of labelled 
antibodies against these have allowed for the study of the specific contribution of 
various cell types to TB-associated CMI. 
The principle component of CMI, the T cell, recognises antigen via three classes of T 
cell receptor (TCR), namely the γδ receptor, CD4 receptor and CD8 receptor5,30,51. 
Unlike γδ cells, the majority of T cells only recognise foreign antigens presented by the 
major histocompatibility complex (MHC) molecules, or by the CD1 family of 
molecules, which are present on the surfaces of so-called antigen-presenting cells 
(APC)
6,30
. The MHC molecules present peptide antigens while the CD1 molecules 
present lipids and glycolipids. More specifically, CD4
+ 
or T helper (Th) cells
 
recognise 
antigen presented in the context of MHC class II molecules, and upon activation, 
produce cytokines which regulate (i.e. help) the activity of other immune cells
30
. The 
classic example of such help is the production of interferon-gamma (IFN-γ) which 
enhances the killing of phagocytosed mycobacteria by macrophages
31
. Cytotoxic CD8
+  
T cells, which recognise antigen presented in the context of MHC class I molecules, 
also produce cytokines, but additionally secrete granzyme and perforin which cause cell 
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lysis (i.e. cytotoxicity) of the specific APC
25
. This mechanism, too, contributes to the 
elimination of mycobacterium-infected cells
9
. To date, despite ever improving insight 
into the cellular and molecular processes involved in the immune response to 
mycobacteria, there is still a poor understanding of what factors contribute to the 
development of active mycobacterial disease, and what markers of immunity might be 
regarded as protective. 
1.3 Lessons from comparative studies of cell-mediated immunity to tuberculosis 
The basic model of the cells involved in CMI and the biology of their interactions has 
been derived from studies of humans and mice, however there can be great variation in 
these components between species. Unlike in humans and rodents, MHC class II 
molecules are expressed on resting T cells in a number of species, e.g. dogs and horses, 
and on resting T cells and granulocytes in rabbits, suggesting that these cells might be 
involved in antigen presentation to CD4
+ 
lymphocytes in these species
14
. In dogs, unlike 
other species, CD4 is strongly expressed on neutrophils
44
, however the functional 
relevance of this is unknown
14. In ruminants and pigs, two subpopulations of γδ cells 
exist, one of which is equivalent to those present in humans and mice, and one which is 
unique to each species
14
. Such species differences can have profound effects on the 
comparative immune response to specific diseases. For example, the group 1 CD1 
molecules which present mycobacterial mycolic acids and lipoarabinomanan occur in 
humans and guinea pigs but not in mice
31
. With this in mind, conclusions drawn from 
animal models should be carefully considered before extrapolating these to other 
species. Nonetheless, such species differences may allow for the identification of 
specific factors which render host species either susceptible or resistant to TB disease. 
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In 1982, Thorns et al investigated TB immunity in experimentally infected guinea-pigs, 
rabbits, rats, ferrets and hedgehogs by comparing antibody responses, CMI (i.e. 
lymphoproliferative and tuberculin skin test responses), and the induced pathology in 
these species
59
. They found that in guinea-pigs and rabbits, intense CMI correlated with 
strong tissue reactions at the site of disease. Rats and hedgehogs displayed poorly 
detectable CMI and subclinical disease with no mortality. The authors concluded that 
the nature of the cell-mediated response was, in part, related to the comparative 
susceptibility to disease. In agreement, Dannenberg and Collins concluded that 
progressive disease in rabbits, mice and guinea-pigs was not due to increasing numbers 
of bacteria, but to the ongoing CMI response of the host
13
.    
Two studies, utilising immunohistochemistry techniques, investigated the lymphocyte 
phenotypes which were associated with granuloma formation in M. tuberculosis-
infected mice and guinea-pigs. While granulomas in mice consisted largely of CD4
+
 
lymphocyte aggregations with CD8
+ 
lymphocytes scattered primarily around the 
periphery of the granuloma
23
, those in guinea-pigs consisted of an apparently random 
mixture of CD4
+
 and CD8
+ 
cells
60
. Such studies may shed light on the fact that mouse 
granulomas do not undergo caseous necrosis
53
 while those of guinea-pigs do, with their 
subsequent development of pulmonary cavitations
10
. While CD8
+ 
T cells may 
contribute to necrosis of granulomas, other studies have pointed to their vital 
contribution to host protection
34,36
. In a study comparing the architecture of granulomas 
in rabbit strains, it was shown that the granulomas of inbred susceptible rabbits 
contained a lower frequency of CD8
+ 
T cells than did those of outbred controls
40
. In 
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agreement, Lyadova et al showed that significantly more CD8
+ 
T cells accumulated in 
lungs of resistant strains of mice than of susceptible strains during TB
37
.     
The growing availability of antibodies against cell markers for a wider variety of host 
species has meant that comparative studies of CMI have now become possible in hosts 
other than traditional laboratory animals. In a series of experiments, Waters et al 
examined in vitro lymphocyte proliferation following mycobacterial antigen stimulation 
of peripheral blood mononuclear cells (PBMCs) from M. bovis-infected cattle, reindeer 
(Rangifer tarandus) and white-tailed deer (Odocoileus virginianus)
63,62,64
. In white-
tailed deer, CD4
+
 lymphocytes proliferated in response to M. bovis purified protein 
derivative (PPD)
63
, while this stimulus resulted in both CD4
+ and γδ TCR+ lymphocytes 
proliferating in cattle
62
. A similar study in cattle also detected proliferation of 
predominantly CD4
+ 
lymphocytes, but also that of CD8
+ 
cells in response to both PPD 
and the mycobacterial proteins early secretory antigenic target 6 (ESAT-6) and culture 
filtrate protein 10 (CFP-10)
39
. In reindeer, CD8
+ and γδ TCR+ lymphocytes proliferated 
in response to ESAT-6/CFP-10
64
. Of interest is that disease progression in these species 
was markedly different. Reindeer presented as a distinctly resistant phenotype and the 
authors speculated that the in vitro findings of the study, i.e. the absence of a CD4
+
 
lymphocyte response and predominant CD8
+
 T cell response, might represent a marker 
of a protective host response. 
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1.4 Lessons from comparative immunity to various members of the Mycobacterium 
tuberculosis complex 
The MTC comprises genotypically closely related organisms which are phenotypically 
distinct, viz. M. tuberculosis, Mycobacterium canettii, Mycobacterium africanum, the 
dassie bacillus, the oryx bacillus, Mycobacterium microti, Mycobacterium pinnipedii, 
Mycobacterium caprae, and M. bovis
29
. Members of the MTC reproduce clonally with 
limited evidence in strains other than M. canettii of the transfer of DNA or of DNA 
recombination
27,57,58
. It is therefore believed that sequential deletions of genetic material 
resulting in large sequence polymorphisms (LSP) have been the primary evolutionary 
events leading to the existence of the various MTC strains
46
 which vary in geographical 
distribution, host preference and virulence
58
. 
Of these strains, M. bovis displays the greatest virulence, causing progressive disease in 
a wide variety of species following natural infection
48
. On the contrary, natural 
infection by M. tuberculosis apparently leads to disease much more rarely in most host 
species. Such differences in virulence between organisms have been exploited in order 
to more carefully understand immune responses to members of the MTC. Low-dose M. 
tuberculosis infection in rabbits, a species regarded as resistant to TB, results in 
negligible pulmonary disease and often in self-cure
28
, and in rabbits infected with high 
doses of M. tuberculosis, disease is limited to the lungs
47
. However, M. bovis infection 
in rabbits results in extrapulmonary dissemination of disease
47
. This picture is mirrored 
in guinea pigs, a susceptible species, in which, in addition to severe lung pathology, 
lymphadenitis is a major element of M. tuberculosis infection
3
. Taken together, these 
studies suggest that protective immunological responses to pathogenic mycobacteria are 
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particularly poor in pulmonary tissues, while dissemination of disease acts as a marker 
of advanced immunological failure. 
Variations in host susceptibility to other members of the MTC may contribute similar 
insights into the protective immunity to TB. Mycobacterium microti can cause severe 
disease in the field vole (Microtus agrestis)
7
 yet experimental infection of this host with 
the dassie bacillus results in minimal pathology
56
. Interestingly, while these organisms 
display varying virulence characteristics in a single host species, both are believed to be 
primarily attenuated as a result of LSPs in the region of difference 1 (RD1) of the MTC 
genome
20,45
. As such, infection studies comparing host responses to these organisms 
may highlight aspects of immunological success or failure in mycobacterial disease. 
 
1.5 Lessons from natural Mycobacterium tuberculosis complex infections in 
animals 
Other than M. tuberculosis, the best known of the MTC stains is M. bovis, the primary 
causative organism of TB in cattle. The wide host range of M. bovis is evidenced by the 
fact that it has become endemic in numerous wildlife species
41,15
. Nonetheless, within 
natural multi-host systems, there is still great variation between hosts with respect to 
their susceptibility to this pathogen. For example, among ruminants in South Africa’s 
Kruger National Park, members of the bovinae subfamily such as African buffalos 
(Syncerus caffer) and greater kudus (Tragelaphus strepsiceros) have proven highly 
susceptible hosts to M. bovis, maintaining, the disease indefinitely within infected 
herds
4,32
. In contrast, in this ecosystem, antelopes such as impalas (Aepyceros capensis), 
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while susceptible to TB, have not been reported to act as maintenance hosts of the 
disease
41,52
. Similarly, in England, free-living foxes which show evidence of exposure 
to M. bovis rarely progress to clinical disease, while badgers have been shown to be 
important maintenance hosts of this organism
15
. Natural M. bovis infection in cattle has 
also pointed to distinct variation in susceptibility to TB between breeds, with Holsteins 
showing a higher prevalence of infection, and increased severity of pathology compared 
to Zebu breeds
2
. 
Such variation between species provides an opportunity to more closely investigate 
immunological responses that might be associated with immunity to TB. As such, a 
limited number of studies have begun to explore these factors using material obtained 
from naturally infected animals. Utilising various cross-reactive anti-human and anti-
dog antibodies, it was shown that in naturally infected badgers, as might be expected, 
CD3
+ 
lymphocytes were predominant in the peripheral cuff of tissue granulomas
8
. Of 
interest was the observation that IgA
+
 and IgG
+ 
plasma cells were more common in 
larger than in smaller granulomas, suggesting that local (rather than generalised) disease 
conditions contributed substantially to the local recruitment, or proliferation, of specific 
cells. Also, these findings were consistent with those of an earlier study of naturally 
infected badgers which detected TB-specific antibody responses only in animals with 
advanced disease
38
. 
However, the limited availability of reagents suitable for use in comparative 
immunology has motivated the use of gene expression studies to detect cellular 
responses to TB.  Fernández de Mera et al. (2008), investigating the expression of 
selected inflammatory and immune response genes in mesenteric lymph nodes of 
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naturally infected Iberian red deer (Cervus elaphus hispanicus), found 17 genes 
differentially expressed by either M. bovis-infected or non-infected animals
18
. Similarly, 
Galindo et al. (2009) investigated the expression of 20,400 genes in splenocytes of 
naturally M. bovis-infected and non-infected European wild boars
21
. They found that 14 
of 17 differentially expressed immune genes were down-regulated in infected animals, 
suggesting TB-associated immune suppression in these individuals
21
. The population 
genetics of these animals was also shown to be associated with disease occurrence, with 
individuals with lower levels of heterozygosity appearing less capable of mounting 
protective responses to natural infection with M. bovis
1
. 
 
1.6 The application of cell-mediated immunity in the diagnosis of tuberculosis 
Despite the relatively recent understanding of CMI, this component of the immune 
response to TB, in the form of the tuberculin skin test (TST), has long been the primary 
diagnostic immunological marker of mycobacterial infection and disease. First 
performed by Mantoux in 1908, the TST determines the inflammatory response to the 
intradermal injection of mycobacterial antigens in the form of purified protein 
derivative (PPD). The response is modulated by cytokines including interferon-gamma 
(IFN-γ), tumour necrosis factor (TNF) and lymphotoxin, which initially cause rapid 
infiltration of neutrophils and macrophages to the injection site
61
. However, by 48 hrs 
after antigen exposure, the cellular component consists primarily of T cells, of which 
the majority are PPD-specific CD4
+ 
T cells which have undergone local 
proliferation
17,61
. While the TST has formed the mainstay of immunological diagnosis 
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of TB in humans and in many animals, there is great variation in the sensitivity of the 
test between host species
11
. A range of TST-reactivity is observed among experimental 
animals with mice displaying a weak response to the TST while guinea pigs are 
strongly reactive
13
. The test has been rigorously evaluated in cattle
43
, and its use in 
other animals is largely based upon knowledge of its use in this species. However, its 
clinical utility in many species is questionable, e.g. the European badger (Meles meles) 
and domestic dogs and cats, and it is inappropriate for TB screening of infected wildlife 
such as badgers and possums (Trichosurus vulpecula), both maintenance hosts of M. 
bovis
11
.  
More recently, the CMI response to TB has been exploited in the development of in 
vitro assays, the so-called interferon-γ release assays (IGRA). First described in 1990 
for cattle
66
, these tests quantify the secretion of IFN-γ by antigen-specific lymphocytes 
following the recognition of mycobacterial peptides by these cells. Field studies in 
cattle have variously determined the IGRA to be either more or less sensitive than the 
TST, however, studies have shown the use of both tests simultaneously to be useful for 
increasing the sensitivity of TB screening
67,65
. As a result, the test has been adapted for 
use in a wide range of hosts
11
 including humans
49
. Animal adaptations of this assay 
have traditionally compared the IFN-γ response to M. bovis PPD and Mycobacterium 
avium PPD in order to specifically identify responses to MTC infection, while newer 
human assays have incorporated peptides simulating ESAT-6 and CFP-10, in place of 
PPD, as MTC-specific stimuli. Homologous genes encoding these proteins have been 
deleted from the BCG genome and are not present in the vast majority of 
  
 
12 
 
nontuberculous mycobacteria. As such, IFN-γ responses to these peptides are regarded 
as highly specific markers of infection by M. tuberculosis or M. bovis.  
Although limited data is available on the use of IGRAs in species other than cattle, the 
test has shown promise for the diagnosis of TB in free-ranging wildlife such as African 
buffalo
24
 and badgers
55
, and in captive species in which the TST is unreliable such as 
monkeys
22
 and cats
54
.    
 
1.7 Conclusion 
Tuberculosis is a disease which affects a wide range of species to a greater or lesser 
degree and experimental infection studies, in several host species, have proven valuable 
for examining specific mechanisms of immunity to TB. The development of diagnostic 
tests in particular hosts have also shown enormous promise when adapted for use in 
other species. Thus, it can be expected that species-specific studies will continue to 
shed light on TB pathogenesis and diagnosis in general. As such, the identification and 
careful investigation of naturally occurring TB in species not conventionally used in 
experimental studies may contribute greatly to a more complete understanding of this 
disease. This thesis therefore seeks to explore the opportunities presented by such 
infections to gain greater insight into the aetiology, transmission, pathogenesis, and 
diagnosis of TB.   
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2.1 Summary 
We report a case of extensive necrogranulomatous pneumonia due to infection with the 
dassie bacillus (mycobacterium tuberculosis complex sp.) in a free-living pregnant adult 
female dassie (rock hyrax-Procavia capensis). A juvenile female dassie from the same 
colony also showed a focal lesion in the lungs suggestive of mycobacterial pneumonia. 
Our findings indicate the widespread occurrence of the dassie bacillus in free-living 
dassies and suggest very high infection rates in some populations. The introduction of 
South African dassies into novel environments should be considered in this light. 
 
 
2.2 Keywords 
Mycobacterium tuberculosis complex; dassie; hyrax; dassie bacillus 
 
 
 
 
 
 
21 
 
2.3 Case Report 
In June 2006, two female dassies (Procavia capensis) were randomly chosen and 
euthanized by an accredited government conservation official on Dasklip Pass, 
Grootwinterhoek Mountains, Western Cape, South Africa (S32"53' 18.45; E19"01' 
49.36), as part of an infectious disease survey of dassies. The dassies were sampled 
from a colony approximately 10 km from Porterville, the nearest human settlement. The 
animals were apparently healthy with no external injuries noted. Due to size difference 
and wearing of the teeth, it was determined that one dassie was an adult female while 
the other was a juvenile (under 3 years). Body condition was good in each female, 
weight was within the reported range for female P. capensis and all other signs were 
apparently normal. The adult female was identified as being pregnant with three 
foetuses. 
Both were subjected to post mortem examination. Macroscopic lesions in the lungs of 
the pregnant adult female dassie consisted of numerous multifocal to confluent, round 
to irregular, 1–20 mm, dull whitish nodules distributed throughout the lung parenchyma 
with little normal lung tissue remaining (Figure 2.1a). The pleura was covered with 
similar slightly raised nodules and plaques. Many lesions showed central caseous 
necrosis with mild calcification. A few nodules showed mild central liquefactive 
necrosis with pus formation. The spleen showed similar lesions (Figure 2.1b). 
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Fig 2.1 Extensive necrogranulomatous lesions observed in (a) the lungs and (b) the 
spleen of the adult female dassie. 
 
23 
 
The liver and placenta had a few small, multifocal, round, raised, dull whitish nodules, 
≤ 1 mm. The lungs of the juvenile dassie contained a focal nodular lesion of 2mm in the 
cranial lobe of the left lung similar in appearance to the adult dassie. No other 
macroscopic lesions were detected in both animals. Samples from the lungs, spleen, 
liver, kidney and heart were collected from the adult dassie in 10% buffered formalin 
for microscopical examination. Fresh samples from the lung were collected aseptically 
from this animal for mycobacterial culture. No samples for histopathological 
examination or mycobacterial culture were collected from the juvenile dassie. 
Microscopically, the lungs of the adult dassie showed numerous multifocal to confluent 
necrogranulomas throughout the parenchyma and the pleura. They consisted of a central 
area of caseous necrosis that was occasionally calcified. This was surrounded by a rim 
of moderate numbers of macrophages and epithelioid cells, and low numbers of 
multinucleated giant cells. Many macrophages and epithelioid cells contained single to 
multiple, small to large, round to oval, clear intracytoplasmic lipid vacuoles. There was 
an outer layer of lymphocytes and plasma cells within a mildly developed fibrous 
capsule. Numerous smaller, multifocal to confluent, often indistinctly outlined 
granulomas, without necrosis and calcification, consisting of vacuolated and normal 
macrophages and epithelioid cells, surrounded by lymphocytes and plasma cells were 
also visible. Some granulomas and necrogranulomas showed central infiltration of low 
to moderate numbers of neutrophils. Similar microscopic lesions were present in the 
spleen. The liver showed a few multifocal granulomas that consisted of moderate to 
large numbers of vacuolated and normal macrophages and epithelioid cells, surrounded 
by low to moderate numbers of lymphocytes and plasma cells. The centre of the liver 
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granulomas showed a small area of coagulation necrosis that was infiltrated by low 
numbers of neutrophils. Ziehl–Neelsen staining of the lung and spleen tissue revealed 
scanty medium-sized, slender, acid-fast bacilli in the cytoplasm of macrophages and 
epithelioid cells comprising the smaller granulomas, and those along the edge of the 
necrotic centre of necrogranulomas. 
Affected lung tissue was prepared and cultured in triplicate with the BACTEC MGIT 
culture system (Becton Dickinson, USA) as previously described
16
. A multiplex 
polymerase chain reaction (PCR) test was performed on heat-killed culture lysates as 
previously described
16
, and identified the organism as a member of the Mycobacterium 
tuberculosis complex with genomic characteristics consistent with the dassie bacillus. A 
subsequent PCR to detect a novel deletion in the dassie bacillus genome, RD1
das
, using 
previously published primers
10
, confirmed the isolation of this organism. Spoligotyping 
showed a pattern similar to that of a previous isolate of the dassie bacillus
14
 and 
dissimilar to M. tuberculosis H37Rv, Mycobacterium bovis BCG, Mycobacterium 
microti
14
 and Mycobacterium africanum subtype I
7
 (Figure 2.2). 
 
 
Fig 2.2 Spoligotype pattern for the dassie bacillus isolate is similar to a previously 
reported dassie bacillus spoligotype pattern and distinct from M. tuberculosis, M. bovis 
BCG, M. microti and M. africanum subtype I. 
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The Mycobacterium sp. defined as the dassie bacillus was first isolated from the lungs 
of a free-living dassie from Nieu Bethesda, in the Great Karoo, Eastern Cape, South 
Africa in the 1950s
15
. It is a member of the M. tuberculosis complex closely related to 
M. microti and M. africanum subtype Ia
2,6,12
. It has been more recently isolated from a 
few captive dassies and a single captive suricate (Suricata suricatta) all of which 
originated from unknown locations in South Africa
2,10,15
 (Göran Bölske, personal 
communication), but it has not been found elsewhere. There are also no further reports 
of it being found in the wild since the original isolation, although no surveys have been 
conducted since then. It appears to have little virulence in rabbits or guinea pigs, species 
which are normally highly susceptible to pathogenic Mycobacteria
13,15
. 
The genome of the dassie bacillus has nine major regions of difference (RD) to that of 
M. tuberculosis, of which five are shared with M. microti and M. africanum subtype 
I
6,10
. A probably crucial difference is the small RD1
das
 deletion in the ESX-1 region. 
This region, which contains the immunopathologically important T-cell antigens of the 
ESAT-6 gene family
4,9
, has been extensively studied and all evidence suggests that it is 
implicated in virulence
3,5,8,11
. Other mycobacterial species which show virulence in 
limited hosts, e.g. M. microti in voles, also have RD1 deletions in the ESX-1 region
1,11
. 
Here we report that the dassie bacillus can be a pulmonary pathogen in free-living 
dassies. Whether this organism is sufficiently pathogenic to contribute in a meaningful 
way to the ecology of the dassie is currently unknown, but a study in this regard is 
probably justified as a general decline in dassie numbers has been observed over the last 
few years (unpublished observations). These animals live in colonies of up to 80 
individuals, which are divided into smaller groups headed by one male and consisting 
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of up to 20 females with their young
17
. The large numbers living in close proximity in 
natural crevices of rocks or boulders, together with the fact that they spend a significant 
proportion of their time huddling together for warmth (they have a poorly developed 
internal temperature regulation), probably provides ample opportunity for the spread of 
the bacillus. The dassie has a relatively slow reproduction rate, giving birth to only two 
or three young after a 6–7 month gestation period17. Young are only sexually mature 
after 16 months, reach adult size at 3 years, and typically live about 10 years. The 
pregnant dassie in this case was severely infected despite previous observations that this 
mycobacterial species did not appear significantly virulent. This could perhaps be 
attributed to immune suppression during pregnancy, although more work would need to 
be done in this area. It may be significant, as it would specifically cause a decrease in 
the breeding population of dassies, with a subsequent decline in numbers, as has been 
observed over the last few years (unpublished observations). Future studies aimed at 
elucidating the association between the decline in the population and the prevalence of 
the dassie bacillus is currently planned. 
It is clear from the captive suricate example that interspecies transmission of the dassie 
bacillus is possible. Whether the dassie bacillus can infect and affect predator species 
(of the dassie or suricate), such as eagles, caracal (Felis caracal) and leopard (Panthera 
pardus), has never been reported, although it seems possible as dassies and suricates are 
important prey species for these animals. The identification of the bacillus in an 
additional geographically distinct population of dassies (situated approximately 600 km 
from the original isolation in Nieu Bethesda) suggests the widespread occurrence of this 
organism in South Africa. The fact that random sampling of two free-living dassies 
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revealed infection in one and suspected lesions in the other, also suggests high rates of 
infection in at least the Dasklip population. These findings contrast markedly with the 
results of the Nieu Bethesda survey in which only 4 of 86 animals were found to have 
granulomatous lung lesions. Of these, the dassie bacillus was isolated from only a 
single animal
15
. Importantly, these findings, combined with the isolation of the 
organism from captive animals originally from South Africa, highlight the need for 
vigilance in preventing the translocation of mycobacterial pathogens during the 
movement of host species. No skin test assays have been done on dassies before, so we 
do not know whether this can be used as a diagnostic or survey instrument. However, 
given the limited genetic differences between the dassie bacillus and the rest of the 
members of the M. tuberculosis complex, the use of bovine or tuberculosis PPD would 
probably be justified. Further studies are underway to determine the relevance of this 
organism in the dassie population. 
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3.1 Abstract 
Mycobacterium tuberculosis infection in dogs is rarely reported and has not previously 
been documented in South Africa. A case of a stray Maltese crossbreed dog with 
extensive multifocal pulmonary tuberculosis due to M. tuberculosis is described. 
Pulmonary granulomas in this case were poorly encapsulated and contained large 
numbers of acid-fast bacteria, highlighting the potential for infected companion animals 
to excrete the pathogen. Treatment of canine tuberculosis is generally not advised, and 
for this reason, euthanasia of diseased animals must be advocated in most instances. 
Physicians and veterinarians must be aware that companion animals with active disease 
caused by M. tuberculosis could act as a potential source of infection. 
 
 
3.2 Keywords 
Canine, dog, Mycobacterium tuberculosis, tuberculosis, zoonosis. 
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3.3 Introduction 
Mycobacterium tuberculosis is one of a number of closely related intracellular bacterial 
pathogens, grouped together as the M. tuberculosis complex (MTC) which cause 
granulomatous disease in a broad range of host species. It is the principal cause of 
human tuberculosis and the extraordinary success of this pathogen is reflected by its 
distribution. It is believed to infect a third of the world’s population, causing 8 million 
new cases of human tuberculosis each year
7
. Despite the widespread occurrence of M. 
tuberculosis, infection by this organism is rarely diagnosed or maintained in free-living 
non-human hosts
1
. The precise nature of this apparent host-adaptation is unresolved, 
presumably involving aspects of both host physiology and ecology
19
. 
‘Spillover’ of M. tuberculosis infection to animals requires prolonged and close contact 
between humans and susceptible animal species and this scenario is classically 
illustrated by the prevalence of M. tuberculosis infection in zoo animals
17
. Companion 
animals living in close contact with tuberculosis patients represent a group at particular 
risk of high levels of exposure to this bacterium; however, cases of canine and feline 
tuberculosis are rarely described
9,22
. South Africa currently experiences an extremely 
high incidence rate for all forms of TB (600/100 000), suggesting that the risk of 
spillover of disease to contact animals will be significant in this country
24
.As far as is 
known this is the 1st documented case of tuberculosis caused by M. tuberculosis in a 
dog in South Africa and the implications of this disease in this high-incidence setting 
are discussed. 
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3.4 Case History 
An adult Maltese crossbreed dog was presented as a stray with an unknown history. The 
dog exhibited generalised alopecia and a multifocal superficial dermatitis. A skin 
scraping failed to identify a cause for the dermatitis. Clinical signs were judged as 
suggestive of Sarcoptes scabei infestation and the dog was treated with doramectin 
(Dectomax, Pfizer AH) at a dose of 200 μg/kg body weight. The following day the dog 
exhibited severe dyspnoea, of apparently acute onset, and died before further treatment 
could be implemented. 
Gross abnormalities detected at post mortem examination were restricted to the 
respiratory tract. The lungs were generally congested and all lobes contained multifocal, 
pale grey areas of consolidation, 2–4mmin diameter. A single tracheobronchial lymph 
node that measured 12 mm in diameter was firm and pale yellow in appearance. 
Specimens from the lungs and bronchial lymph nodes were collected for 
histopathological examination. Lung sections showed multifocal to confluent 
necrogranulomas consisting of central coagulative to occasionally liquefactive necrosis 
that were infiltrated by low numbers of neutrophils. Some necrotic foci showed mild 
central calcification. The necrotic areas were surrounded by a moderately developed 
granulomatous layer consisting of large numbers of macrophages and epithelioid cells, 
moderate numbers of lymphocytes and plasma cells, and low numbers of fibroblasts, 
with the formation of an indistinct and poorly developed outer fibrous capsule (Fig. 
3.1). Scanty Langhans’ multinucleated giant cells were present. The remainder of the 
lungs showed moderate numbers of small multifocal to confluent granulomas consisting 
of macrophages, as well as widespread alveolar and interstitial infiltration of numerous 
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macrophages, lymphocytes and plasma cells, with moderate fibrinous oedema. There 
was mild to moderate epithelialisation of pneumocytes. The pleura was moderately 
thickened as a result of fibrosis and the infiltration of low numbers of macrophages, 
lymphocytes and plasma cells. Ziehl-Neelsen (ZN) staining revealed numerous acid-fast 
bacilli in the cytoplasm of macrophages and epithelioid cells of the necrogranulomas 
and granulomas, and in individual macrophages throughout the parenchyma (Fig. 3.2). 
The tracheobronchial lymph node sampled showed effacement of the normal 
architecture, which was replaced by extensive caseous necrosis with prominent central 
calcification. The area of necrosis was surrounded by large numbers of macrophages 
and epithelioid cells, moderate numbers of lymphocytes and plasma cells, low numbers 
of fibroblasts, and scanty Langhans’ multinucleated giant cells. Numerous acid-fast 
bacilli were demonstrated, using ZN staining, in the cytoplasm of macrophages and 
epithelioid cells, as well as in the caseous necrotic centre. 
 Samples of the tracheobronchial lymph node, mesenteric lymph node, and lung tissue 
were homogenised separately, decontaminated and subjected to culture in BACTEC 
mycobacterial growth indicator tube (MGIT) medium containing polymixin B, 
amphotericin B, nalidixic acid, trimethoprim, and azlocillin (PANTA) (Becton 
Dickinson, USA) as previously described
23
. Acid-fast bacilli were identified in each 
culture. A multiplex polymerase chain reaction (PCR) test performed on heat-killed 
culture lysates, as previously described
23
, identified the bacteria as M. tuberculosis. 
This isolate was shown to belong to the Beijing strain of M. tuberculosis by the IS6110 
restriction fragment length polymorphism (RFLP) genotyping technique, as previously 
described
18
 (Fig. 3.3). 
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Fig. 3.1: Periphery of a typical pulmonary granuloma showing an indistinct division 
between the lymphocyte cuff and surrounding lung tissue (haematoxylin and eosin) 
 
 
Fig. 3.2: Pulmonary granuloma showing numerous acid-fast bacilli (stained bright red), 
demonstrated by using Ziehl Neelsen staining. 
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Fig. 3.3: IS6110 restriction fragment length polymorphism patterns of (a) a reference 
strain of M. tuberculosis (Mt14323) with selected fragment lengths indicated in 
kilobases, (b) a non-Beijing strain of M. tuberculosis, (c, d) M. tuberculosis Beijing 
strains isolated from human subjects, and (e) the M. tuberculosis strain isolated in this 
case.   
 
 
 
 
37 
 
3.5 Discussion 
Canine tuberculosis is rarely diagnosed worldwide and as far as could be established 
has not previously been reported in South Africa. In the present case, as is most 
commonly found in reported cases of canine tuberculosis, the causative organism was 
M. tuberculosis, and such infections have been associated with close contact between 
companion animals and human tuberculosis patients
9,14
. Notably in this case, the 
infection was caused by a Beijing strain of the pathogen, a genotype associated with 
high transmission rates and pathogenicity
15
. 
An estimation of the prevalence of canine TB in South Africa must be speculative. 
Human tuberculosis is most prevalent in resource-poor environments in which 
veterinary services are also rarely readily available. Given that the diagnosis of canine 
TB is time-consuming and relies on sophisticated and costly procedures, it will remain 
under-diagnosed. Reports from the 1st half of the 20th century estimated prevalence 
rates of canine TB, based on necropsy studies, at between 0.1 and 6.7 % (median 1.9 %) 
in various European cities
20
. These figures may approximate the scenario in South 
Africa, where the national incidence of human pulmonary TB
24
 is more than double that 
of the European settings described above
2
. In the modern setting, however, antibiotic 
treatment of human TB, by reducing the severity and chronicity of disease, will 
probably affect the likelihood of disease transmission to contact animals. Also, 
differences in pet population age structures and differences in pet-owner interactions 
will affect the probability of transmission and disease in different settings. Additionally, 
control of Mycobacterium bovis has reduced the contribution of this pathogen to the 
incidence of canine TB
8
.  
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Ante mortem prevalence rates in dogs in the European settings described above are 
recorded as varying between 0.04 and 1 %16 and 0.15 and 2 %
20
. These figures are 
spurious, however, as dogs often present with sub-clinical mycobacterial disease or 
with vague, non-specific symptoms which vary according to the organ systems affected. 
Clinical signs of canine tuberculosis are most commonly associated with respiratory 
disease and may include pyrexia, listlessness, inappetance, weight loss, a non-
productive cough, retching, vomition and dyspnoea
16
. Non-respiratory signs can include 
diarrhoea, hepatomegaly, polyuria and polydypsia
16
. Radiographic evidence of canine 
TB can often be non-specific but may include signs of pleural and/or pericardial 
effusion, tracheobronchial lymph node enlargement, multifocal interstitial pneumonia 
(with a nodular to mixed nodular/alveolar pattern), hepatomegaly, splenomegaly and 
ascites
14
. 
The ante mortem diagnosis of canine TB is also complicated by the fact that dogs are 
poor responders to the intradermal tuberculin test commonly used in cattle and humans. 
In a recent study, 14 dogs experimentally infected with M. tuberculosis failed to 
respond to intradermal injections of M. tuberculosis and M. bovis purified protein 
derivative (PPD) tuberculin
3
. The use of higher concentrations of M. tuberculosis PPD 
in the form of Old Tuberculin, as used in the diagnosis of primate TB, may be more 
appropriate for eliciting a skin response
21
. Alternative in vitro diagnostic assays are 
available for a wide variety of host species, but their use in dogs has not been reported
4
. 
Definitive diagnosis of tuberculosis relies on histopathology of affected tissues and 
culture of the causative bacterium. The lesions of tuberculosis in carnivores differ from 
those in other species. Nonspecific granulomatous inflammation comprising 
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macrophages is the usual manifestation and the lesions often have a sarcomatous 
macroscopic appearance. Typical tubercles are not commonly found and caseation 
necrosis, calcification and giant cells are rare findings. Fibrous encapsulation and 
calcification are usually not present, while acid-fast bacilli may be numerous
6
. The 
present case generally exhibited similar pathology but microscopic caseation necrosis 
with calcification was quite prominent in the 1 tracheobronchial lymph node sampled 
for histopathology. 
The treatment of canine tuberculosis must be considered in light of the fact that 
diseased animals present a potential source of human infection. The transmission of M. 
tuberculosis from companion animals to humans has not been described; however, the 
potential risk for zoonotic disease is apparent. This report has shown that infected dogs 
may carry high mycobacterial loads and granulomas may be poorly contained in these 
animals, allowing for the excretion of large numbers of bacteria (Figs 3.1 and 3.2). This 
is evidenced by the isolation of M. tuberculosis from laryngeal and rectal samples from 
7 of 48 dogs and cats living in close contact with  tuberculosis patients
13
. Also, 
Bonovska et al.(2005) have shown transmission of M. tuberculosis from infected to 
healthy dogs under experimental conditions
3
. 
Multiple-drug therapy must always be used in the treatment of tuberculosis in order to 
reduce the potential for the development of bacterial drug resistance. Current 
recommendations are a 6 to 9 month regimen combining a fluoroquinolone (e.g. 
enrofloxacin or ciprofloxacin) (5–15 mg/kg per os, daily), clarithromycin (5–10 mg/kg 
per os, daily) and rifampicin (10–20 mg/kg per os, daily)10. Alternatively, a 
combination of rifampicin (10–20 mg/kg per os, daily) isoniazid (10–20 mg/kg per os, 
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daily) and ethambutol (15 mg/kg per os, daily) given for 2 months followed by a 
combination of rifampicin and isoniazid for at least a further 4 months can be used
10
. 
Such lengthy treatments require intense commitment by the pet owner and this scenario 
presents a serious risk of noncompliance with treatment protocols. The dangers of this 
include the ongoing potential for zoonotic transmission of infection and importantly, the 
opportunity for the development of drug resistant mycobacterial strains. This is of 
particular importance for drugs such as the fluoroquinolones that are used in the 
treatment of recurrent and multi-drug resistant (MDR) TB in humans
5
.Additionally, 
treatment may require careful monitoring for the development of severe side-effects to 
drugs such as isoniazid
11
 and rifampicin
12
. For these reasons, it is widely believed that 
the treatment of canine TB is ill advised and euthanasia of diseased animals must be 
advocated in the majority of cases
8,21
 (D Gunn-Moore, University of Edinburgh, pers. 
comm., 2007). 
The implications of canine tuberculosis within the context of the South African human 
tuberculosis epidemic remain undefined. However, veterinarians and physicians must 
be aware of the potential for companion animals to act as reservoirs of M. tuberculosis. 
This is particularly true for veterinarians and veterinary staff working with animals 
from communities experiencing high levels of human tuberculosis. 
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4.1 Abstract  
 Mycobacterium tuberculosis infection in dogs can result in clinical tuberculosis (TB), 
and diseased companion animals pose a risk as a reservoir of human infection. 
Assessment of this risk is hampered by the fact that there are currently no validated 
immunological assays for diagnosing TB in this species. A limited postmortem canine 
TB survey was performed, and a canine TB-specific interferon-gamma release assay 
(IGRA) was developed to assess the prevalence of canine M. tuberculosis infection and 
disease in high-risk dogs. The prevalence of canine TB in a random sample of stray 
dogs was 1% (95% CI: 0-5%), while the prevalence of immunological sensitivity to M. 
tuberculosis in dogs in contact with smear-positive TB patients was 50%. Our findings 
suggest that the risk of progression to TB in M. tuberculosis infected dogs is low. 
Nonetheless, the risk of transmission of this pathogen from smear-positive TB patients 
to contact dogs is high and this should be considered when assessing the zoonotic risks 
associated with such companion animals. 
 
 
4.2 Keywords 
Canine, dog, interferon-gamma release assay, Mycobacterium tuberculosis, 
tuberculosis, zoonosis  
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4.3 Introduction 
Mycobacterium tuberculosis, the primary agent of human tuberculosis (TB), is 
uncommonly isolated from cases of animal TB. However, natural infection by this 
organism can occur in a wide variety of animal hosts following close, prolonged contact 
with infectious humans
18
. Indeed, post mortem surveys performed in European cities in 
the first half of the 20
th
 century determined the prevalence of canine TB as varying 
between 0.1 and 6.7 % (median 1.9%) with the majority of these being caused by M. 
tuberculosis
20. South Africa currently experiences one of the world’s highest national 
incidence rates for all forms of TB (600/100 000)
26
 with extremely high levels of 
culture-positive pulmonary TB (1000/100 000) diagnosed in some settings
9
. 
In such environments, epidemiological investigations of both infection and disease have 
evidenced high levels of M. tuberculosis transmission between people
16,24
, and it can be 
expected that companion animals living in such environments will be at high risk of 
infection by this pathogen. Infected animals can act as reservoirs of TB and 
transmission of this disease between dogs has been shown under experimental 
conditions
1
. However, TB is prevalent in resource-poor settings in which sophisticated 
veterinary services are generally unavailable and where cases of canine TB will remain 
largely undetected.  
In addition to the lack of clinical data about canine TB, a comprehensive understanding 
of this disease is further limited by the absence of practical immunological tests for its 
diagnosis. These typically rely on the detection of antigen-specific T lymphocyte-
mediated responses as surrogate markers of exposure to the causative organism
7,15
. This 
principle is employed in the in vivo tuberculin skin test (TST) which characterises the 
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inflammatory response to mycobacterial purified protein derivative (PPD). Similarly, 
the interferon-gamma (IFN-γ) release assay (IGRA) quantifies the in vitro release of 
IFN-γ by antigen-specific lymphocytes stimulated by mycobacterial peptides. In cattle, 
the TST has been adapted to determine either the response to a single injection of 
Mycobacterium bovis PPD (PPD
bov
) or the comparative response to PPD
bov 
and 
Mycobacterium avium PPD (PPD
av
) in order to distinguish between infection by M. 
bovis and environmental mycobacteria
7
. Historically, IGRAs have measured 
comparative responses to PPD
bov
 and PPD
av 7
, while more recently, proteins largely 
specific to M. tuberculosis and M. bovis (early secretory antigenic target 6 kDa (ESAT-
6) and culture filtrate protein 10 kDa (CFP-10)) have been used in IGRAs to detect 
infection by these organisms
5,7
. No standard protocols exist for the TST in canines as it 
has long been believed that this test is unreliable in dogs
11
 and that the use of regular M. 
tuberculosis and M. bovis PPD as TST stimuli are uninformative
1,21
. Additionally, there 
are no reports of the use of IGRAs in this species
6
. 
The aim of this study was to investigate and develop a suitable protocol (using the TST 
and IGRA) for identifying M. tuberculosis exposure in dogs, and to determine the 
prevalence of canine TB and the risk of M. tuberculosis transmission to dogs in a high-
risk population in South Africa.  
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4.4 Materials and Methods 
4.4.1 Post mortem survey 
One hundred stray dogs euthanised at an animal welfare organisation servicing 
communities experiencing high transmission rates of TB in Cape Town, South 
Africa
24,16
, were included in this study. A complete post mortem examination was 
performed on each animal and samples of retropharyngeal and ileo-caecal lymph nodes, 
lung tissue, and all abnormal tissues, were processed routinely for histopathology and 
stained with Haematoxylin and Eosin, and Ziehl-Neelsen (ZN) stains. As previously 
described, additional samples of these tissues were processed for mycobacterial 
culture
19
. Cultures were speciated by multiplex polymerase chain reaction (PCR)
25
 and 
16S ribosomal RNA gene sequencing
12
, and genotyping of M. tuberculosis isolates was 
done by IS6110 restriction fragment length polymorphism (RFLP) methods
23
. Culture 
of M. tuberculosis was regarded as definitive of M. tuberculosis infection. 
4.4.2 Animals 
Dogs at high risk of exposure to M. tuberculosis were identified as animals living on the 
same property as a person being treated for sputum smear-positive pulmonary TB. 
Tuberculosis patients were approached through an existing human TB research program 
of Stellenbosch University (SU) and written consent was given by owners to examine 
their dogs. Testing of animals was performed at the owner’s home. Data relevant to the 
degree of exposure of pets to human patients was recorded: i.e. whether dogs had access 
to the patient’s home, whether they slept in- or outside the home, and whether they had 
regular access to left-over human meals. Control animals, with a negligible risk of M. 
tuberculosis exposure (i.e. putatively unexposed), were identified through a private 
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veterinary practice situated in a high-income, low TB-incidence area, and owners of 
these gave consent for their inclusion in the study. Ethical approval to approach TB 
patients in contact with dogs was obtained from the SU Committee for Human 
Research, and to perform animal work, from the SU Committee for Experimental 
Animal Research.  
4.4.3 Single and Comparative TST 
Prior to the TST, dogs were sedated with medetomidine hydrochloride (30 µg/kg, i/m) 
(Domitor, Novartis SA Animal Health, Isando, South Africa). The TST was performed 
by intradermal injections of 0.1 ml of a 50% solution (in phosphate buffered saline 
(PBS)) of M. tuberculosis Old Tuberculin (OT) (1250 IU) (Statens Serum Institut, 
Copenhagen, Denmark) in the right medial thigh and 0.1 ml of a 50% solution of M. 
avium PPD (WDT, Hoyerhagen, Germany) (1250 IU) in the left medial thigh. A 50% 
solution was used as optimisation of the testing protocol showed that intradermal 
injection of full-strength OT resulted in a moderate non-specific dermatitis, with focal 
necrosis at the injection site. Sedation was reversed with Atipamezole hydrochloride 
(150 µg/kg, i/m) (Antisedan, Novartis AH). Sites of the TST were examined after 72 
hours and the diameter of any ensuing tissue reaction was recorded. A cut-off of 5 mm 
between positive and negative responses, for either the comparative or single TST, was 
predicted based on previous studies of intradermal skin testing in dogs
4,21
.     
4.4.4 Interferon gamma release assay 
At the time of the TST, blood was collected into Vacutainer
®
 tubes containing sodium 
heparin (Becton Dickinson, Plymouth, England). Within two hours of collection, blood 
was diluted 1:5 in RPMI 1640 supplemented with 2 mM L-glutamine, 100 IU/ml 
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penicillin and 0.1 mg/ml streptomycin (Sigma-Aldrich, Kempton Park, South Africa). 
Aliquots of the whole blood suspension were incubated in triplicate in 96-well plates 
(200 µl/well) with 10 µg/ml PPD
Av
 (Statens Serum Institut (SSI), Copenhagen, 
Denmark), 10 µg/ml M. tuberculosis PPD (PPD
Tb
) (SSI), 10 µg/ml 
phytohaemagglutinin (PHA) (Sigma-Aldrich), and in medium alone, respectively. 
Additionally, whole blood suspensions from 13/24 TB-exposed dogs and all control 
dogs were incubated with 10 µg/ml recombinant ESAT-6/CFP-10 fusion protein from 
M. tuberculosis (a kind gift from T. Ottenhoff, Leiden University). Following 5 days of 
incubation, supernatants from each treatment group were harvested, pooled, and stored 
at -20°C. Interferon-gamma concentrations ([IFN-γ]) of pooled samples were 
determined using the Quantikine
® 
canine IFN-γ enzyme-linked immunoassay (ELISA) 
kit (R&D Systems, Minneapolis, USA). Antigen-stimulated samples were assayed in 
duplicate. For each animal, the [IFN-γ] of the unstimulated sample ([IFN-γ]nil) was 
subtracted from those of each stimulated sample to obtain final IFN-γ response results, 
i.e. [IFN]
esat6/cfp10
, [IFN]
tb
, [IFN]
av
, and [IFN]
pha
. Comparative IGRA results were 
calculated as [IFN]
tb 
- [IFN]
av
.  
 
4.4.5 Statistical analysis and determination of IGRA cut-offs 
Differences in [IFN]
esat6/cfp10 
between the TB-exposed and control groups were analysed 
using the unpaired t-test. Differences in comparative IGRA responses between these 
groups were similarly analysed by comparing their relative PPD
tb
 responses (calculated 
as: [IFN-γ]tb / [IFN-γ]tb + [IFN-γ]av).    
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The cut-off between positive and negative [IFN]
esat6/cfp10 
was defined as the upper limit 
of the 95% CI of the [IFN-γ]esat6/cfp10 values of all control animals. Due to the specificity 
of the ESAT-6/CFP-10 assay
3,5
 this test was used as a gold standard to determine cut-
off values for the comparative IGRA using an ROC curve analysis.   
 
4.5 Results 
4.5.1 Post mortem survey 
Acid-fast (ZN positively-stained) bacteria were cultured from tissue samples from six 
animals. Four cultures were confirmed as M. tuberculosis (4% prevalence of infection, 
95% CI: 1-10%) (Fig. 4.1), one as Mycobacterium intracellulare, and one as a M. 
avium species. Macroscopic and microscopic lesions consistent with TB were detected 
in a single culture positive animal (described by Parsons et al.
19
) (1% canine TB disease 
prevalence, 95% CI: 0-5%).  
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Fig. 4.1 IS6110 Mycobacterium tuberculosis restriction fragment length polymorphism 
patterns of (a) a reference strain, with selected fragment lengths indicated in kilobases, 
(b) the strain isolated from a dog with clinical tuberculosis, and (c, d, e) strains isolated 
from dogs with no gross or histopathological lesions of TB.    
 
 
 
 
 
 
 
52 
 
4.5.2 Animals 
Of 23 TB-exposed animals, 18/23 (78%) slept outside the home. However, 12/23 (52%) 
had some access to the home, and 19/23 (83%) received remains of human meals. 
4.5.3 Tuberculin skin testing  
Of 17 TB-exposed dogs tested, 14 had OT TST responses of less than 5 mm, and none 
had responses greater than 10mm. In 12 of these animals, the PPD
av 
TST gave no 
response at all, while 2 had responses greater than 5 mm. The limited TST responses to 
both OT and PPD
av
 precluded further analysis of these data.   
4.5.4 Interferon-gamma release assay 
In vitro IFN-γ responses to mycobacterial PPD and ESAT-6/CFP-10, and the IGRA 
results for selected animals are presented in Tables 4.1 and 4.2. For this study, mean 
[IFN-γ]nil was 8 pg/ml (S.D. +/-22 pg/ml) and [IFN-γ]pha was greater than 500 pg/ml for 
all samples. A positive ESAT-6/CFP-10 IGRA result was calculated as [IFN]
esat6/cfp10
 > 
200 pg/ml. Using an ROC analysis, with the ESAT-6/CFP-10 IGRA as a gold standard, 
a cut-off for the comparative IGRA result was calculated as 161 pg/ml (sensitivity 0.75, 
specificity 0.9, AUC = 0.93). Mean [IFN]
esat6/cfp10 
and mean relative PPD
tb 
responses 
were significantly higher in TB-exposed dogs than un-exposed dogs (p < 0.05) (Figs 4.2 
and 4.3). These statistics gave us confidence to accept a positive result from either 
IGRA (according to the criteria described) as a true marker of immunological responses 
to M. tuberculosis in dogs. As such, the prevalence of M. tuberculosis infection in dogs 
in South Africa was determined as 12/24 (50%) within a high risk population and 1/16 
(6%) within a population at low risk of exposure to TB. 
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Table 4.1 IFN-γ concentrations in antigen-stimulated blood samples, and IGRA results, 
for selected putatively TB-unexposed dogs. 
 
  IFN-γ (pg/ml)   IGRA result 
animal 
ID [IFN]tb [IFN]av [IFN]tb-av [IFN]esat6/cfp10   
Comparative 
assay
1 
ESAT-6/CFP-10 
assay
2 
C1 89 159 -70 89  - - 
C2 262 905 -643 125  - - 
C3 464 1414 -950 192  - - 
C4 0 262 -272 132  - - 
C5 120 119 1 55  - - 
C6 1561 813 748 191  + - 
C7 248 185 63 71  - - 
C8 100 187 -87 126  - - 
C9 6 109 -103 27  - - 
C10 356 195 161 25  - - 
C11 71 145 -74 15  - - 
C12 537 1189 -652 104  - - 
C13 110 614 -504 33  - - 
C14 160 7 153 60  - - 
C15 1967 1893 74 45  - - 
C16 100 2 98 68   - - 
 
-, negative = 1[IFN]
tb-av 
< 161 pg/ml; 2[IFN]
esat6/cfp10 
< 200 pg/ml 
+, positive = 1[IFN]
tb-av ≥ 161 pg/ml; 2[IFN]esat6/cfp10 ≥ 200 pg/ml 
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Table 4.2 IFN-γ concentrations in antigen-stimulated blood samples, and IGRA results, 
for selected TB-exposed dogs. 
 
  IFN-γ (pg/ml)   IGRA result 
animal ID [IFN]tb [IFN]av 
[IFN]
tb-
av [IFN]esat6/cfp10   
Comparative 
assay
1 
ESAT-6/CFP-
10 assay
2 
E1 130 212 -82 ND  - ND 
E2 390 382 8 ND  - ND 
E3 0 143 -143 ND  - ND 
E4 89 120 -31 ND  - ND 
E5 2874 1528 1346 ND  + ND 
E6 141 239 -98 ND  - ND 
E7 1159 224 935 ND  + ND 
E8 161 134 27 ND  - ND 
E9 0 0 0 ND  - ND 
E10 605 416 189 ND  + ND 
E11 131 82 49 ND  - ND 
E12 470 72 398 64  + - 
E13 58 169 -111 98  - - 
E14 35 0 35 0  - - 
E15 1676 1545 131 2242  - + 
E16 249 266 -17 197  - - 
E17 4540 108 4432 4104  + + 
E18 216 0 216 265  + + 
E19 1593 992 601 574  + + 
E20 1453 136 1317 503  + + 
E21 1133 438 695 1156  + + 
E22 3758 68 3690 4642  + + 
E23 0 0 0 0  - - 
E24 294 189 105 361   - + 
-, negative = 1[IFN]
tb-av 
< 161 pg/ml; 2[IFN]
esat6/cfp10 
< 200 pg/ml 
+, positive = 1[IFN]
tb-av ≥ 161 pg/ml; 2[IFN]esat6/cfp10 ≥ 200 pg/ml 
ND, not done 
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Fig 4.2 ESAT-6/CFP-10 stimulated whole blood interferon gamma responses in TB-
exposed and unexposed dogs showing significant differences in these (p < 0.05). 
 
 
Fig 4.3 Relative PPD
tb 
interferon gamma responses ([IFN-γ]tb / [IFN-γ]tb + [IFN-γ]av) 
from whole blood assays performed on TB-exposed and unexposed dogs showing 
significant differences in these (p < 0.05). 
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4.6 Discussion 
In order to investigate the prevalence of canine TB in an urban South African setting, 
and to mitigate possible ethical and emotional concerns surrounding such a study, we 
performed a post mortem survey of stray dogs presented to an animal welfare 
organisation. Such sampling is not subject to the bias inherent in examining owner-
presented animals only, and its value is supported by the fact that we have identified the 
first documented case of canine TB in South Africa
19
. The prevalence of this disease in 
the South African context (1%, 95% CI: 0-5%) is similar to those in European cities, as 
determined at necropsy, in the early part of the 20
th
 century (median 1.9%, range 0.1 to 
6.7%)
20
. Indeed, the higher historical European values are attributable, to some degree, 
to the prevalence of M. bovis infections in these settings
20
.
7
 These data are from 
randomly sampled animals and it should be noted that the prevalence of TB in dogs 
with known TB exposure can be expected to be higher. 
In addition, we cultured M. tuberculosis from lymph nodes of 3/100 dogs with no gross 
or histopathological lesions of TB. Similarly, M. bovis was cultured from the carcases 
of 23/756 foxes (Vulpes vulpes) in a study which identified only a single case of gross 
TB
8
 and from 3/62 coyote (Canis latrans) carcasses in a study in which no animals 
presented with macroscopic TB lesions
2
. These data indicate that in canids, true 
infection levels by pathogenic mycobacteria can be substantially higher than those 
determined by the detection of gross pathology at necropsy. Mycobacterium 
tuberculosis strains identified in this study (Fig 1) were representative of strains 
commonly associated with human infection in Cape Town
22
. 
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To assess M. tuberculosis infection rates in dogs, we made use of TB tests widely used 
and well characterised in other species
6,7
. In the majority of tested animals, intradermal 
injection of 0.1 ml of a 50% solution of OT in PBS (1250 IU) resulted in inflammatory 
responses of 4 mm in diameter or less, and did not allow for a clear distinction between 
responses. Also, TST results were inconsistent with those of the IGRA. Together, these 
findings support those of other studies which have found the TST ineffective in dogs
1,11
.    
Additionally, using a novel IGRA to detect immunological sensitivity to M. 
tuberculosis antigens in dogs, we identified a 50% infection rate in dogs in contact with 
smear-positive TB patients. While overnight whole blood IGRAs have been 
successfully validated in a number of species, we chose to stimulate blood cultures for 5 
days, since longer culture periods have been shown to be more sensitive for the 
detection of antigen-specific IFN-γ responses5. The IGRA has a number of advantages 
over the TST. In our experience, sedation of dogs was required to perform the TST, 
while this is not the case for the IGRA. Furthermore, animals need only to be examined 
once, test outcomes are objective, the test can be designed to be highly specific by using 
well-defined antigens, and the test allows for the inclusion of positive and negative 
controls. The significant distinction in IFN-γ responses between TB-exposed and 
control animals is indicative that the assay detects true infection in dogs (p < 0.05) and 
a significant agreement between the ESAT-6/CFP-10 and comparative IGRA results 
implies that this test is robust.  As such, this assay appears to be highly suited for use in 
canines, and may prove useful in future investigations.   
Many reports of canine TB highlight intimacy of contact between owners and their pets 
as an important risk factor for TB transmission. Hawthorne et al., in a study 
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investigating animals living with TB patients in Edinburgh, found that 37/37 (100%) of 
dogs lived in the owner’s house and 18/37 (51%) slept in the same room as the owner13. 
However, we have shown that in a setting where contacts between pets and humans are 
less intimate than previously described
10,13,17
, levels of M. tuberculosis transmission 
may remain high.  
This study has identified high levels of M. tuberculosis transmission to dogs living in 
contact with smear-positive TB patients and a canine TB prevalence rate of 1% in an 
urban South African setting. Our findings indicate that in many cases, the risk of 
transmission of M. tuberculosis infection, from humans with pulmonary disease to 
contact animals, should be regarded as high. In humans, fewer than 10% of infections 
result in clinical disease
15
 and our data supports previous experimental and clinical 
findings that indicate that the risk of progression to active TB in infected dogs is 
similarly low
11,14,21
. Nonetheless, this risk must be evaluated on a case-by-case basis, as 
diseased animals could act as reservoirs of human infection. Such consideration is of 
particular importance where animals are living in contact with high-risk individuals 
such as children or immunocompromised patients, or have been exposed to multidrug-
resistant strains of M. tuberculosis.  
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_______________________________________________ 
CHAPTER 5 
Development of an in vitro lymphoproliferative assay 
for the characterisation of the canine immune response 
to tuberculosis 
______________________________________________________________________ 
 
 
5.1 Abstract 
Specific lymphocyte response patterns during tuberculosis (TB) may reflect markers of 
host susceptibility or resistance to this disease. In order to characterise the canine cell-
mediated immune response during TB, the possibility of adapting a flow cytometric 
lymphoproliferative assay used in various ruminant species was explored. A 
combination of direct and indirect cell labelling techniques was developed to allow 
multi-colour flow cytometric analysis of canine PBMCs. Significant neutrophil 
contamination of these cells was identified as a limitation for the development of the 
proliferative assay.  
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5.2 Introduction 
Cell-mediated immunity (CMI) has been recognised as the major component of the 
protective immune response to tuberculosis (TB)
8
. As such, a clearer understanding of 
the mechanisms of this response may allow for a more rational approach to the 
development of new vaccines and diagnostic assays, or the identification of markers of 
host susceptibility or resistance, to this disease. One such field of inquiry has been the 
elucidation of the contribution of the various lymphocyte subsets to the CMI of TB. 
Classically, CD4
+ 
T-helper (Th) 1 lymphocytes have been regarded as central to the 
protective immunity to TB
8
, however, more recently, focus has been placed on CD8
+
 
cytotoxic lymphoctes as being important in this response
7
. 
In a series of studies, Waters et al. investigated lymphoproliferative responses to 
various M. bovis antigens in experimentally-infected white-tailed deer (Odocoileus 
virginianus), cattle, and reindeer (Rangifer tarandus grantii)
15,16,17
. They reported that 
in reindeer, a species that is regarded as being resistant to TB
11
, CD8
+
 and γδ T cell 
receptor (TCR)
+
 lymphocytes were the predominant cells which proliferated on 
exposure to M. bovis antigens
17
. In contrast, CD4
+
 and γδ TCR+ lymphocytes in cattle15, 
and CD4
+
 lymphocytes in white-tailed deer
16
, both regarded as species which are 
susceptible to TB
17,12
, were the predominant lymphocyte subsets responding to these 
antigens. They have speculated that the predominant CD8
+
 lymphoproliferative 
response, in the absense of a significant CD4
+ 
response, might represent a marker of 
resistance to TB
17
.  
Tracking of proliferation of specific lymphocyte subsets is possible by flow cytometric 
analysis of cell division. One such protocol requires the isolation of peripheral blood 
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mononuclear cells (PBMCs) followed by the marking of these with an intercalating 
fluorescent dye, such as PKH26. Cell proliferation can then be detected as a reduction, 
by half, in the fluorescence of daughter cells. The isolation of human PBMCs is most 
commonly done by the centrifugation of diluted whole blood over a solution of 
polysucrose and sodium diatroziate Ficoll-Hypaque with a density of 1.077 g/ml
3,13
. 
This achieves the separation of red cells (1.093 – 1.096 g/ml) and granulocytes (1.087 – 
1.092 g/ml) from lymphocytes (1.070 g/ml)
13
. The use of this technique has been 
reported in canine studies. However, using this technique, high levels of granulocyte 
contamination of PBMCs were noted by Bonnefont-Rebeix et al. (2006)
2
, and the 
inconsistency in canine PBMC separation protocols in the published literature suggests 
poor reproducibility of this procedure
9,14
.  
Buurman et al. (1982) measured the mean densities of canine lymphocytes (1.071 g/ml) 
and neutrophils (1.077 g/ml) and concluded that the limited difference between these 
precludes the simple adoption of human PBMC separation protocols for use with canine 
samples
4
. Further complicating the development of such a protocol were their findings 
of substantial variation in cell densities between individual animals, and the fact that 
some individuals showed transient changes in granulocyte densities over time. 
Nonetheless, it has been reported that separation of canine PBMCs over a diluted 
solution of FH (1.070 g/ml) was effective in reducing the degree of neutrophil 
contamination
2
.  
A further complication of flow cytometric analysis of canine PBMCs is the limited 
availability of suitably labelled antibodies directed against canine leukocyte epitopes. 
As such, studies describing normal ranges of canine lymphocyte subsets have only used 
65 
 
single-parameter staining protocols
1,5,6
.Such limitations preclude the detailed analysis 
of canine immune responses. 
This study aimed to optimise the isolation of canine PBMCs and develop a 
methodology for the flow cytometric characterisation of the canine adaptive immune 
response to M. tuberculosis by investigating modifications to the standard 
immunological techniques discussed above.     
   
5.3 Materials and Methods 
5.3.1 Animals 
Twenty dogs were used in this study. They were both male and female, of various ages 
and breeds, privately owned and randomly selected from households with or without a 
primary human TB case. Ten ml of blood was obtained by venipuncture of the cephalic 
or jugular vein and transferred to Vacutainer tubes containing sodium heparin (Becton-
Dickinson, Franklin Lakes, NJ, USA). Ethical permission for the study was obtained 
from the Committee for Experimental Animal Research of the Faculty of Health 
Sciences, Stellenbosch University (Ref: P05/08/011). 
5.3.2 Multi-parameter flow cytometric phenotyping of canine lymphocyte subsets 
Canine PBMCs were incubated with unlabelled mouse IgG anti-dog CD4, mouse IgG 
anti-dog CD8, or mouse IgG anti-dog γδ T cell receptor (Leukocyte Antigen Biology 
Laboratory, University of California, Davis, CA, USA)) at 4°C for 30 min. 
Subsequently, these cells were sequentially incubated with Cyanine 5 (Cy5) conjugated 
goat anti-mouse IgG (SouthernBiotech, Birmingham, AL, USA) and fluorescein 
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isothionate (FITC) conjugated rat anti-dog CD5 (Serotec, Kidlington, UK), a canine 
lymphocyte marker, under the same conditions. Following each incubation step, cells 
were washed twice with 1% bovine serum albumin (BSA) in phosphate buffered saline 
(PBS). Quantification of Cy5- and FITC-labelled cells was done on a FACSCalibur 
flow cytometer (Beckton Dickinson, Franklin Lakes, NJ,USA).  
5.3.3 Characterisation of neutrophil contamination of canine PBMCs separated over 
Ficoll-Hypaque 
Canine PBMCs were resuspended in RPMI 1640 (Sigma-Aldrich, Saint Louis, MO, 
USA) and 10 µl of this suspension was diluted in 10 µl of Trypan Blue (Sigma-
Aldrich). Ten µl of this suspension was loaded onto a haemocytometer and after 2 min. 
(in order to allow for cell adherence to the cover slip), cells were visualised at 40 x 
magnification. Differential counts of adherent and non-adherent cells were made 
according to cell morphology (Table 5.1). 
Additionally, PBMC subsets were analysed by flow cytometry by direct and indirect 
two-colour fluorescent labling of cells using anti-CD5 and anti-CD4 antibodies as 
described above. Neutrophils were identified as CD5
-
/CD4
+
cells and relative numbers 
of these cells were recorded.   
 
 
 
 
67 
 
 
Table 5.1 Morphological characterisation of canine leukocytes isolated over 
Histopaque-1077 
Cell type Morphological description 
Unadherent Small (approx. 10 µm in diameter), round to oval, bright cell   
Adherent Large (> 40 µm in diameter), dark, spreading cell with "fried-egg appearance" 
        
 
5.3.4 Optimisation of canine PBMC isolation from whole blood 
For each animal, ten ml of blood was diluted 1:1 in phosphate-buffered saline (PBS). 
Histopaque-1077 (Sigma-Aldrich, Saint Louis, MO, USA) was diluted 95:5 and 9:1 
with sterile water to obtain Ficoll-Hypaque solutions with densities of 1.073 and 1.069 
g/ml, respectively. Subsequently, conditions for the isolation of PBMCs from randomly 
selected blood samples were varied according to Ficoll-Hypaque density (1.077, 1.071, 
and 1.069 g/ml), centrifugal force applied (350, 500, 1200 x g), and duration of 
centrifugation (20, 30, and 40 min.).  In all cases, diluted blood was layered over 
Histopaque-1077 solutions and centrifuged at room temperature. Using a Pasteur 
pipette, PBMCs were harvested from the interface of the PBS/plasma and Histopaque-
1077 fractions and washed three times in PBS. For selected samples, relative PBMC 
counts and relative neutrophil counts were visually made as described above. 
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5.3.5 PKH26 staining of PBMCs for lymphoproliferation studies 
Briefly, PBMCs (2 x 10
7
) were suspended in 1ml of Diluent C (provided in the PKH26 
kit) and added to 1ml of a 4 x 10
-6 
molar PKH26 solution (Sigma-Aldrich, Saint Louis, 
MO, USA), a fluorescent dye which is incorporated into the lipid regions of the cell 
membrane. Following incubation at room temperature for 4 min., PKH26 staining was 
stopped by addition of 2 ml 1% BSA-PBS. Cells were then washed 3 times in RPMI 
1640 before resuspension at 1 x 10
6
/ml in RPMI 1640 supplemented with 10% foetal 
calf serum (FCS), 2 mM L-glutamine, 100 IU/ml penicillin and 0.1 mg/ml streptomycin 
(Sigma-Aldrich, Saint Louis, MO, USA). Aliquots of the cell suspension were 
incubated in 48-well plates with either 10 µg/ml phytohaemagglutinin (PHA) or in 
medium alone for 5 days. Following incubation, cells were harvested, washed, and 
prepared for flow cytometric analysis.  
 
5.4 Results 
5.4.1 Multi-parameter flow cytometric phenotyping of canine lymphocyte subsets 
Two-colour labelling of canine PBMCs was achieved by a combination of indirect and 
direct methods. Such labelling allowed for highly reproducible two-parameter 
phenotypic analysis of these cells with insignificant cross-reactivity of the secondary 
antibody (Fig 5.1). In a randomly selected animal, differential CD4
+ 
lymphocyte counts 
in PBMC samples obtained under 3 different separation conditions were 32%, 33%, and 
33%, respectively (Fig 5.1). 
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5.4.2. Characterisation of neutrophil contamination of canine PBMCs separated over 
Ficoll-Hypaque 
In all cases, flow cytometric analysis of canine PBMCs revealed a significant number of 
CD5
-
/CD4
+
 neutrophils in this population (e.g. Fig 5.2). For all samples, relative 
adherent cell counts determined using a haemocytometer were approximately half those 
of the relative neutrophil counts obtained by flow cytometric analysis, and were 
uncorrelated with monocyte counts (Table 5.2). While these data do not specifically 
identify the adherent cells as neutrophils, it confirms that the adherent cell count can be 
used as a useful proxy for neutrophil contamination of PBMCs. This technique was 
used subsequently in evaluating and optimising separation conditions for canine 
PBMCs.     
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Fig 5.1 Flow cytometric analysis of CD5
+
/CD4
+
 cells showing reproducibility of results 
using a combination of direct and indirect staining technique. PBMCs, from a single 
animal, were separated under various conditions: (a) 600 x g, 90% Histopaque, (b) 600 
x g, 95% Histopaque, (c) 1000 x g, 95% Histopaque.  
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Fig 5.2 Flow cytometric scatter plots of PBMCs from a randomly selected individual 
indicating (a) typical light scatter characteristics of canine lymphocytes and neutrophils 
in PBMCs and (b) relative CD5
-
/CD4
+ 
neutrophils in this sample. 
 
Table 5.2 Relative cell counts in canine PBMCs as determined by visual cell counting 
and flow cytometry.   
  
Separation 
conditions   PBMC subsets (flow cytometry)   
Animal  
Centrifugal 
force (x g) 
Ficoll 
(%)   lymphocytes monocytes neutrophils 
Adherent cell 
count 
1 400 100 
 
32 14 54 28 
2 400 100 
 
25 9 66 31 
3 600 95 
 
40 33 25 17 
3 1500 95   44 32 22 11 
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5.4.3 Optimisation of canine PBMC isolation from whole blood 
Neutrophil contamination of PBMCs isolated under similar conditions from blood 
samples from various dogs ranged between 6 and 78% (Table 5.3). In all cases, 
neutrophil contamination of PBMCs was less in samples separated over a Ficoll-
Hypaque density of 1.069 g/ml than 1.077 g/ml (Table 5.4); however, separation over 
1.069 g/ml resulted in a profound decrease in total PBMC isolation (Table 5.5). For a 
single animal, whole blood separated over 1.077 g/ml for either 20 or 30 min., showed a 
large reduction in contaminating neutrophils, but with a negligible reduction in the 
number of PBMCs isolated (Table 5.5). However, increasing the duration of 
centrifugation from 30 to 40 minutes resulted in both an increase in neutrophil 
contamination in PBMCs and a marked reduction in total PBMCs recovered (Table 
5.6).        
 
Table 5.3 Neutrophil counts, inferred by enumeration of glass-adherent cells, in canine 
PBMCs separated over a density of 1.077 g/ml.      
Animal Duration (min) Centrifugal force (x g) Adherent cells (%) Neutrophils (%) 
1 30 350 5 10 
2 30 500 8 16 
3 30 500 3 6 
4 30 500 25 50 
5 25 500 21 42 
6 25 500 39 78 
7 25 400 29 58 
8 25 400 31 62 
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Table 5.4 Relative PBMC yields from 5 dogs (A-E) separated over various Ficoll-
Histopaque densities.   
  Relative PBMC yield (%)   
Ficoll-Hypaque 
density (g/ml) A B C D  E 
1.077 100 100 100 100 100 
1.073 26 41 93 100 90 
1.069 20 65 30 82 — 
 
 
 
 
Table 5.5 Relative neutrophil counts, from 5 dogs (A-E), in PBMCs separated over 
various Ficoll-Histopaque densities. 
  Relative neutrophil count (%)   
Ficoll-Hypaque 
density (g/ml) A B C D E 
1.077 10 16 28 42 60 
1.073 10 62 14 46 43 
1.069 14 12 10 26 — 
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Table 5.6 Relative neutrophil counts and PBMC yields from 4 animals (A-D) separated 
over Ficoll-Histopaque (1.077 g/ml) for various lengths of time.              
  Relative neutrophil count (%)   Relative PBMC yield (%) 
Duration (min.) A B C D 
 
A B C D 
20 — — — 28   — — — 100 
30 10 16 50 6 
 
100 100 100 97 
40 36 26 61 —   37 61 68 — 
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5.4.4 PKH26 staining of PBMCs for lymphoproliferation studies 
PKH26 staining of PBMCs resulted in bright, homogeneous fluorescence of all cells, 
and allowed for the determination of PKH26 fluorescence in various lymphocyte 
subsets (Fig 5.3). Following 4 days of incubation with PHA, all lymphocytes, and all 
lymphocyte subsets showed no loss in PKH26 fluorescent intensity (e.g. Fig 5.4).    
 
 
Fig 5.3 Flow cytometric analysis of PKH26 fluorescence of unstimulated canine 
PBMCs:  (a) scatter plot showing intense PKH26 fluorescence of both CD5
+ 
and CD5
- 
cells, (b) scatter plot showing PKH26 fluorescence of CD4
+
 (and CD5
+
) cells, and (c) 
histogram of PKH26 fluorescence of CD5
+
/CD4
+ 
cells indicating homogenous PKH26 
staining. 
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Fig 5.4 Histogram of PHA-stimulated canine CD5
+
/CD4
+
 lymphocytes showing 
negligible loss of PKH26 fluorescence. 
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4.5 Discussion   
The difficulty in obtaining a pure canine PBMC population has been noted by 
numerous investigators
2,2
 and is reflected by the wide variation in conditions under 
which these cells are obtained
9,14
. In this study, using dogs of various breeds, no 
optimal Ficoll-Hypaque density was identified for the separation of PBMCs. Separation 
of canine PBMCs over 1.069 g/ml Ficoll-Hypaque resulted in a dramatic reduction in 
the number of PBMCs isolated, while separation over 1.073 g/ml Ficoll-Hypaque 
resulted in inconsistent changes in the relative proportion of contaminating neutrophils 
(Tables 5.4 and 5.5). However, centrifugation of whole blood over Ficoll-Hypaque for 
30 min. was identified as optimal for this procedure (Table 5.6). 
Using a combination of direct and indirect labelling techniques, two-parameter flow 
cytometric leukocyte analysis was shown to be possible for dogs despite the limited 
spectrum of canine reagents (Fig 5.1). Canine neutrophils express the cell marker CD4
10
 
making differentiation between these and CD4
+ 
lymphocytes impossible using single-
parameter labelling. Two-parameter labelling of cells, i.e combining the CD4 marker 
with a lymphocyte marker (CD5), allows for highly specific of immunophenotyping of 
these cells as evidenced by this study (Fig. 5.1)    
However, it was not possible to adapt the PKH26 assay to track canine PBMC 
proliferation. This may, in part, have been due to the neutrophil contamination of 
PBMCs. PKH26, released by neutrophils undergoing apoptosis during the course of the 
assay, would be available for uptake by proliferating lymphocytes, thereby masking the 
loss of fluorescence by these cells, and negating the assay signal. Under these 
circumstances, the use of a flow cytometric proliferation assay which labels only those 
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cells undergoing proliferation, rather than all cells, would be more useful. As such, 
bromodeoxyuridine BrDU proliferation assays, which quantify the utake of BrDU by 
proliferating cells, may prove to be a more suitable for use in canines. 
In conclusion, while two-colour labelling of canine leukocytes was achieved by a 
combination of direct and indirect labelling, this study was complicated by unforseen 
species-specific factors. The potential for substantial biological differences in leukocyte 
subsets between species should therefore be considered when adapting immunological 
assays for use in new animal models. 
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6.1 Abstract 
Background Early diagnosis of simian tuberculosis (TB) is vital to prevent transmission 
of this disease. We evaluated the ability of the QuantiFERON-TB Gold (In-Tube 
Method) assay (QFG-IT) to detect TB in chacma baboons (Papio ursinus). Methods 
Fifty-one baboons were tested using the Tuberculin Skin Test (TST) and the QFG-IT. 
Baboons testing positive, and animals exposed to infected individuals, were euthanised 
and subjected to necropsy. Selected tissues were processed for histopathology, 
mycobacterial culture and genetic speciation. Results Tuberculosis was confirmed in 
one TST positive/QFG-IT positive animal and one TST negative/QFG-IT positive 
animal. One TST positive/QFG-IT negative animal and five TST negative/QFG-IT 
negative animals were confirmed uninfected following necropsy. Conclusion The QFG-
IT correctly detected TB in two baboons, including one TST negative individual and 
correctly identified six baboons as uninfected, including one TST positive individual. 
The QFG-IT shows promise as a sensitive, specific test for TB in chacma baboons. 
 
 
6.2 Keywords 
ELISA; ESAT-6/CFP-10; interferon-gamma release assay; non-human primate; 
tuberculin skin test; tuberculosis 
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6.3 Introduction 
Old World monkeys are highly susceptible to tuberculosis (TB) caused by the acid-fast 
mycobacteria Mycobacterium tuberculosis and Mycobacterium bovis (members of the 
M. tuberculosis complex (MTC))
15,20
. Both pathogens have been associated with severe 
disease in chacma baboons (Papio ursinus)
8,10
. Typically, exposure of baboons to M. 
tuberculosis occurs in captive environments where close contact between infected 
humans and animals allows for aerosol transmission of the bacterium
8,14
. We have, 
however, detected cases of TB caused by M. tuberculosis in freeliving baboons in a 
peri-urban environment in Cape Town, South Africa (T. A. Gous, unpublished data), 
presumably as a result of these animals scavenging on human waste. This behaviour has 
previously been associated with outbreaks of TB caused by M. bovis in free-living 
baboons elsewhere
10,19
. 
Tuberculosis in Old World monkeys commonly results in debilitating pulmonary 
disease
9,15
. Given suitable conditions, infected monkeys can therefore act as a source of 
transmission of TB to other individuals and pose a health risk to humans
9,10
. As such, 
early detection of TB in captive non-human primates (NHP) is vital. 
The tuberculin skin test (TST) has been the mainstay of TB detection in many mammals 
and is widely used in NHP
2,7
. The test measures cell-mediated delayed-type 
hypersensitivity in response to the intradermal injection of mammalian old tuberculin 
(MOT) derived from M. tuberculosis or purified protein derivative (PPD) derived from 
either M. tuberculosis or M. bovis. However, MOT and PPD are poorly defined and 
immunological cross-reactivity to various other mycobacterial species can cause false 
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positive results to this test. Also, false negative results (skin test anergy) have been 
described in a number of monkey species including baboons
3,8,13,20
. 
 More recently, in vitro whole blood assays have been developed to diagnose TB in a 
wide range of species, including NHP
7,9
. These tests quantify the production of the 
cytokine interferon-gamma (IFN-γ) by antigen-specific lymphocytes in response to 
stimulation by mycobacterial proteins. Such tests have classically compared the 
differential IFN-γ responses to M. bovis PPD and M. avium PPD in order to 
differentiate infection by members of the MTC from infections by nontuberculous 
mycobacteria respectively. Alternatively, proteins which are highly specific to M. 
tuberculosis and M. bovis can be used as antigenic stimuli in order to identify infection 
by one of these pathogens. This strategy is employed in the human diagnostic test, the 
Quantiferon-TB Gold (In-Tube Method) assay (QFGIT) (Cellestis Limited, Carnegie, 
Australia), which utilises peptide antigens simulating proteins which are highly specific 
to most members of the MTC
16
. Genes encoding these proteins have been deleted from 
the genome of the attenuated strain of M. bovis Bacille Calmette-Guérin (BCG), which 
is used as a live vaccine against TB
12
. Accordingly, this test is useful in humans as it 
distinguishes M. tuberculosis infection from vaccination with BCG. 
This study aimed to determine if the QFG-IT might be used for the diagnosis of TB in 
captive chacma baboons, some of which had previously been vaccinated with 
recombinant BCG (r-BCG). 
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6.4 Materials and methods 
6.4.1 Animals 
Fifty-one chacma baboons were included in this study. The baboons were housed 
singly, outdoors, with full visual, olfactory and auditory contact with conspecifics at the 
Delft Animal Facility of the South African Medical Research Council in accordance 
with the South African National Guidelines for the Care and Use of Animals for 
Scientific Purposes. Tactile contact, including grooming with adjacent individuals, was 
possible through grooming panels of wire mesh. The diet consisted of 200 g of a 
pelleted feed (Aquafeeds, Cape Town, South Africa) each morning and a 200 g portion 
of fresh fruit or vegetables each afternoon. Once per week the diet was supplemented 
with a 100 g slice of bread covered with 5 ml Vitamin C syrup. Fresh water was 
supplied twice daily. This colony had intermittently experienced cases of TB and the 
current study was initiated following the identification of two TST positive individuals 
during routine screening of the colony. A number of individuals in the colony had 
previously been vaccinated with BCG during a clinical trial
6
. Prior to TB testing and 
euthanasia, animals were tranquilised by intramuscular injection of 10 mg/kg ketamine 
hydrochloride.  
6.4.2 Tuberculosis tests 
Tuberculin skin tests were performed by intradermal injection of 0.1 ml (5000 IU) of 
Mycobacterium bovis PPD (WDT, Hoyerhagen, Germany) into the left upper 
palpebrum. The site of the TST was monitored daily for 72 hours and the inflammatory 
response characterised as previously described
2
. Concurrently, 1 ml of blood was 
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collected into QFG-IT TB Antigen, Mitogen Control (positive control), and Nil Control 
(negative control) tubes, respectively, and processed according to the manufacturer’s 
instructions. The TB Antigen tubes contain peptide antigens simulating the MTC-
specific proteins 6 kD Early Secretory Antigenic Target (ESAT-6), Culture Filtrate 
Protein 10 (CFP-10), and TB 7.7(p4)
1
. The Mitogen tubes contain phytohaemagglutinin 
(PHA), a potent stimulus for IFN-c production by lymphocytes in a wide variety of 
species
18
. Briefly, following vigorous shaking, tubes were incubated at 37°C for 16 to 
24 hours, after which supernatants from these tubes were harvested and stored at -20°C. 
Interferon-gamma concentrations in supernatants were determined by enzyme-linked 
immunosorbant assay (ELISA) using the QFG-IT ELISA kit and test results were 
interpreted according to the manufacturer’s criteria for human patients. Additionally, 
IFN-γ concentrations in supernatants from selected individuals were determined using 
the ELISA
PRO
 kit (Mabtech AB, Nacka Strand, Sweden) utilising antibodies previously 
shown to detect IFN-γ of chacma baboons5. Samples were assayed in duplicate and the 
minimum detectable dose (MDD) was calculated as twice the average IFN-γ 
concentration of the Nil Control samples of all animals. A positive result was 
determined by the formula: [IFN-γ]Antigen – [IFN- γ]Nil > MDD. Finally, blood from a 
randomly selected chacma baboon was diluted 1:5 in RPMI 1640 supplemented with 2 
mm L-glutamine, 100 IU/ml penicillin and 0.1 mg/ml streptomycin. Aliquots of the 
whole blood suspension were stimulated in 96-well plates (200 µl/well) with either 10 
µg/ml phytohaemagglutinin (PHA) for 5 days or 2 µg/ml Staphylococcal Enterotoxin B 
(SEB) for 2 days. All reagents were purchased from Sigma-Aldrich, South Africa. 
Interferon-gamma concentrations in supernatants from PHA- and SEB-stimulated wells 
were determined using both QFG-IT ELISA and Mabtech ELISA
PRO
 kits. 
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6.4.3 Postmortem examination 
All animals which tested positive with either the TST or QFG-IT were euthanised by 
intravenous injection of 200 mg/kg sodium pentobarbitone. Additionally, five animals 
in close contact with confirmed TB cases were euthanised as a biosecurity precaution. 
Carcases were subjected to complete postmortem examinations. Samples of all major 
organs and macroscopically diseased tissues were routinely prepared for 
histopathological examination. Samples of tracheobronchial lymph nodes, pulmonary 
tissue and macroscopically diseased tissues were processed for mycobacterial culture 
and genetic speciation according to the presence of genomic regions of difference (RD) 
1, 4, 9 and 12 as previously described
17,21
. 
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6.5 Results 
6.5.1 Detection of baboon IFN-γ by enzyme-linked immunosorbant assay 
Positive signals for IFN-c were obtained from both the PHA- and SEB-stimulated blood 
samples using both the QFG-IT and Mabtech ELISA kits (Table 6.1). Notably, the IFN-
γ concentration from samples stimulated with PHA for 5 days was surprisingly low. 
Similarly, IFN-γ concentrations from 25 samples incubated overnight in QFG-IT 
Mitogen Control tubes (containing PHA) were negligible or undetectable in all but a 
single case, i.e. B515 (Table 6.1).  
6.5.2 Tuberculosis tests 
Two animals tested positive by the TST: B750 (grade 4 response) and B675, an animal 
previously vaccinated with r-BCG (grade 3 response) (Table 6.2). All other animals 
were TST negative. Because IFN-γ responses were undetectable in the mitogen-
stimulated samples, QFG-IT results were interpreted according to an algorithm 
provided by the manufacturer using only results from the Nil Control and TB Antigen 
tubes. Two animals tested positive by the QFG-IT (B750 and B749), while all other 
animals, including those previously vaccinated with r-BCG, tested negative with this 
test (Tables 6.2 and 6.3). The MDD for the ELISA
PRO 
assay was determined as 43 
pg/ml (Nil Control result range: 0–83.7 pg/ml; mean: 21.5 pg/ml). Results obtained for 
those animals tested using the ELISAPRO assay concurred with the QFG-IT results (as 
shown in Table 3).  
 
  
 
Table 6.1 Mitogen-stimulated whole blood interferon-γ responses in chacma baboons as determined by the QFG-IT and Mabtech ELISAPRO kit 
(Mabtech) systems. 
    Interferon-gamma (mean (+/- S.D.))      
Stimulation conditions Duration  QFG-IT (IU/ml) Mabtech (O.D.) Mabtech (pg/ml) Comment 
10 µg/ml PHA in 96-well plate 5 days 1.08 0.74 n/d randomly selected baboon 
2 µg/ml SEB in 96-well plate 2 days 20.11 3.68 n/d randomly selected baboon 
Mitogen Control Tube (PHA) overnight 6.03 n/d n/d 1/25 baboons 
Mitogen Control Tube (PHA) overnight 0.17 (+/- 0.10) n/d n/d 9/25 baboons 
Mitogen Control Tube (PHA) overnight n/d 0.19 (+/- 0.16) 40.6 (+/- 27.5) 15/25 baboons 
PHA, phytohaemagglutinin; SEB, Staphylococcal Enterotoxin B (SEB); n/d, not done 
 
8
9
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Table 6.2 QFG-IT results, Tuberculin Skin Test (TST) results, and Post Mortem 
examination (PM)/mycobacterial culture results for chacma baboons euthanised during 
this study. 
    QFG-IT (IU/ml)     
Category Baboon 
Nil Control 
Tube 
TB Antigen 
Tube Result TST  PM/culture 
TB Infected B749 0.15 5.94 + - + 
TB Infected B750 0.68 21.58 + + + 
BCG-vaccinated B675 0.05 0.06 - + - 
TB Contact B515 0.41 0.29 - - - 
TB Contact B748 0.14 0.09 - - - 
TB Contact B755 0.08 0.08 - - - 
TB Contact B787 0.2 0.16 - - - 
TB Contact B788 0.07 0.13 - - - 
-, negative; +, positive    
 
 
Table 6.3 Tuberculosis test results for chacma baboons previously vaccinated with 
recombinant BCG. 
  Mabtech ELISA
PRO 
(pg/ml) QFG-IT (IU/ml) 
Baboon 
ID 
Nil Control 
Tube 
TB Antigen 
Tube Result 
Nil Control 
Tube 
TB Antigen 
Tube Result 
B675 n/d n/d n/d 0.05 0.06 - 
B687 18.6 14.0 - 0.12 0.13 - 
B692 10.4 8.8 - 0.16 0.09 - 
B710 11.2 7.0 - 0.09 0.09 - 
B732 0 0 - 0.07 0.07 - 
B733 37.8 44.1 - 0.16 0.15 - 
B734 15.3 12.0 - 0.11 0.12 - 
B738 6.4 4.4 - 0.12 0.08 - 
-, negative  
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6.5.3 Pathology, histopathology and mycobacterial culture 
Animals B675, B749 and B750 (positive responders) and B515, B748, B755, B787 and 
B788 (contact animals) were euthanised. Postmortem examination of B750 showed 
marked, multifocal to confluent, subacute to chronic, necrogranulomatous to 
pyogranulomatous inflammation affecting the lungs, pleura, lymph nodes 
(tracheobronchial, mediastinal and intrathoracic along the aorta), spleen and focally in 
the epicardium of the left ventricle of the heart. A prominent, round to oval, 150 mm · 
50 mm, raised granuloma filled with 8 ml of pus, and attached to the lungs by a few 
fibrous adhesions, was visible in the diaphragmatic pleura. 
Histopathology confirmed the macroscopic findings and also revealed multifocal 
microgranulomas in the liver and kidneys. The large granulomas consisted of 
occasional central caseous necrosis surrounded by a moderately developed layer of 
macrophages and epithelioid cells, and moderate to large numbers of multinucleated 
giant cells. This layer was surrounded by low to moderate numbers of lymphocytes and 
plasma cells and a poorly to well developed fibrous capsule. Some granulomas showed 
central liquefaction with infiltration of moderate to large numbers of neutrophils. The 
microgranulomas in the liver and kidney consisted of nodular aggregates of 
macrophages, epithelioid cells and multinucleated giant cells and low numbers 
lymphocytes and plasma cells. Ziehl-Neelsen staining was negative for acid-fast bacilli 
in all sections of all organs. 
Postmortem examination of B749 showed a single, mildly encapsulated, round, 7 mm, 
raised necrogranuloma in the dorsal surface of the right cranial lung lobe (Fig. 1). The 
tracheobronchial lymph node showed a focal, indistinctly outlined, 3 mm, poorly 
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encapsulated, slightly raised oval granulomatous area in the cortex. Microscopically, 
the lung granuloma revealed a caseous necrotic centre that was infiltrated by low 
numbers of neutrophils, and surrounded by a layer consisting of low to moderate 
numbers of macrophages and epithelioid cells. This was surrounded by an indistinct 
outer layer consisting of low numbers of lymphocytes and plasma cells. There was an 
incomplete but fairly well developed fibrous capsule that extended into the necrotic 
centre. Some sections from macroscopically normal lung samples showed multifocal 
granulomatous bronchopneumonia. 
These microgranulomas consisted of nodular aggregates of macrophages, epithelioid 
cells and low numbers of multinucleated giant cells, with some microgranulomas that 
were surrounded by a thin layer of lymphocytes and plasma cells, and a poorly 
developed fibrous capsule. Some microgranulomas showed central coagulative necrosis 
with infiltration of low numbers of neutrophils and mild to moderate calcification of the 
necrotic centre was occasionally noted. The microgranulomas were occasionally 
situated in the mucosa of bronchioles where they often extended through the respiratory 
epithelium to communicate with the airway lumen. There were numerous 
microgranulomas that consisted of macrophages, epithelioid cells and low numbers 
multinucleated giant cells in the cortex and paracortex of the tracheobronchial lymph 
node. Ziehl-Neelsen staining was negative for acid-fast bacilli in all sections of all 
organs. 
Postmortem examinations of B515, B675 B748, B755, B787 and B788 did not show 
any macroscopic and microscopic lesions suggestive of tuberculosis, and all sections of 
all organs examined were negative for acid-fast bacilli with ZN-staining. 
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Acid-fast bacteria were cultured from lymph node and lung lesions from B749 and 
B750 and confirmed as M. tuberculosis. 
 
 
 
 
Fig 6.1 A single, mildly encapsulated, raised necrogranuloma (indicated by arrow) in 
the dorsal surface of the right cranial lung lobe (B749). 
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6.6 Discussion 
The early diagnosis of TB is essential to prevent outbreaks of this disease in NHP 
colonies. In settings where a colony is presumed to be TB-free, and where the risk of 
infection is low, the TST provides for a simple, cost-effective assay for monitoring the 
infection status of the colony. However, the sensitivity of the TST has been reported in 
various species to vary between 60–85%7. Thus, this test may fare poorly at controlling 
an epizootic or for monitoring a population at high risk of infection. In such scenarios 
the use of a second test in conjunction with the TST can improve the sensitivity of 
infection screening
9,20
.  
Our study is the first to demonstrate that a human in vitro TB assay, the QFG-IT, can be 
used to detect TB infection in chacma baboons. The study investigated naturally 
occurring TB in a captive colony of baboons and as such the number of cases 
contributing to our findings is limited. Nonetheless, the use of the QFG-IT in 
conjunction with the TST improved the sensitivity of infection screening of the colony, 
and our results support a presumption that the QFG-IT may have greater specificity 
than the TST. The specificity of the QFG-IT is attributable to the use, as antigenic 
stimulants, of peptide antigens simulating the proteins ESAT-6, CFP-10, and TB 
7.7(p4)
1
. Few non-tuberculous mycobacteria contain genes which encode homologous 
proteins, and these genes are deleted from the TB vaccine strain BCG
1,12
. As such, an 
immune response to these proteins may, with a great degree of confidence, be attributed 
to prior exposure to M. tuberculosis or M. bovis. In our study, this specificity was 
demonstrated in the case of B675, a baboon previously vaccinated with r-BCG. While 
TST positive, this animal was QFG-IT and tissue culture negative. This suggests that 
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the TST result was probably caused by immunological priming to BCG proteins 
contained in the M. bovis PPD. These findings suggest that the QFG-IT could be useful 
in differentiating BCG vaccination from TB infection in baboons. 
The sensitivity of the QFG-IT is indicated by the ability of the test to correctly identify 
TB in a TST negative individual (B749). In this case, gross tuberculous lesions were 
limited to a single granuloma in a lung lobe and indistinct granulomatous inflammation 
in the tracheobronchial lymph node (Fig. 1). This picture suggests early infection or 
recent progression of disease, as in our experience, at the time of TB diagnosis by TST, 
baboons often present with advanced disease, as in the case of B750. It has been 
reported that for some monkey species, most infected individuals will convert to TST 
positivity within 8 weeks of infection
11,20
. However, this is not true for all individuals, 
and some previously TST positive animals can revert to being TST negative
3,13,20
. 
While the cause of the TST anergy is speculative, our results suggest that in this case 
the QFG-IT may have detected infection prior to the development of a positive TST. 
A proviso for the use of the QFG-IT system for the diagnosis of TB in baboons (and 
possibly in other monkeys) is that the positive control tube (Mitogen Control) cannot be 
used for the assay in accordance with the manufacturer’s instructions. Of 25 animals 
tested, a positive control result was obtained for only a single individual, B515 (Table 
1). Additionally, 5-day whole blood culture with PHA resulted in a low IFN-c response 
in a single baboon, and weak whole blood responses to PHA stimulation in other 
monkeys has been reported
20
. This means that a positive control can not be 
conveniently included in the assay and negative test results must be interpreted in this 
light. In itself, the lack of a positive control does not significantly affect the validity of 
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the QFG-IT test in healthy humans, and this may be the case for NHP
4
. Indeed, the 
more common NHP TB test, the TST, is performed without a positive control. 
However, the lack of positive control responses in this study detracts from the 
significance of our results as negative TB Antigen responses can not be critically 
evaluated. This limitation of the QFG-IT must be considered if further attempts are 
made to validate the use of this assay in NHP, possibly by the addition of an appropriate 
mitogen, such as SEB, to the Mitogen Control tube. 
The QFG-IT offers numerous advantages as an ancillary TB test. Blood samples are 
taken directly into tubes containing the antigens and incubated in these closed tubes. 
Incubation conditions need not be sterile and do not require CO2 or humidification, and 
a standard blood tube centrifuge is used to harvest supernatants. Initial processing of 
samples, therefore, may be possible in moderately equipped field laboratories, zoos, and 
primate handling facilities. Of particular utility is the fact that the QFG ELISA kit can 
be used to determine test results. Commercial human laboratories offering the test can 
therefore process baboon samples without modification to the human protocol. If the 
QFG-IT were to be appropriately validated for baboons, these attributes would make 
this assay highly suitable for TB testing of individuals or small numbers of animals on 
an ad hoc basis. 
In conclusion, while the sensitivity of the QFG-IT to diagnose TB in chacma baboons is 
undetermined, this highly specific test shows promise as a simple, practical addition to 
the TST, and would be particularly useful in settings in which commercial in vitro NHP 
TB tests are unavailable. As such, our experience strongly suggests that further 
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investigation of the use of the QFG-IT for the diagnosis of TB in NHP may prove 
highly rewarding. 
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CHAPTER 7 
Detection of Mycobacterium kansasii infection in a 
rhesus macaque (Macaca mulatta) using a modified 
QuantiFERON-TB Gold assay 
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7.1 Abstract 
A modification of a highly practical human interferon-gamma release assay for the 
diagnosis of tuberculosis (TB), the QuantiFERON-TB Gold (In-Tube Method) (QFG-
IT), was evaluated for diagnosing natural mycobacterial infection in rhesus macaques 
(Macaca mulatta). All animals in a captive colony were tested using the QFG-IT and 
tuberculin skin test (TST). Animals testing positive to these tests were euthanised and 
necropsied. Selected tissues were processed for histopathology and mycobacterial 
culture, and positive cultures were speciated by Mycobacterium tuberculosis complex 
polymerase chain reaction (PCR) and 16S rRNA gene PCR sequencing techniques. 
Mycobacterium tuberculosis was cultured from a TST-positive/QFG-IT-positive animal 
which showed gross pulmonary pathology typical of TB. Additionally, Mycobacterium 
kansasii was cultured from a TST-negative/QFG-IT-positive animal which had no 
pathological or histopathological signs of mycobacterial infection. The detection of M. 
kansasii infection in a QFG-IT-positive animal which showed no evidence of disease 
indicates that this test might be a highly sensitive tool for the diagnosis of 
mycobacterial infection in rhesus macaques. However, these findings highlight the 
limitations of the QFG-IT to specifically detect infection by the pathogens M. 
tuberculosis and Mycobacterium bovis.     
 
7.2 Keywords 
Diagnosis; interferon-gamma; Mycobacterium kansasii; Mycobacterium tuberculosis; 
rhesus macaque; tuberculosis 
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7.3 Introduction 
Rhesus macaques (Macaca mulatta) are highly susceptible to tuberculosis (TB) caused 
by the bacteria Mycobacterium tuberculosis and Mycobacterium bovis
4,15
. In these 
monkeys the disease almost invariably results in severe pulmonary pathology and 
coughing is commonly an early clinical sign of illness
4
. This symptom, resulting in 
aerosolisation of the pathogen, provides a mechanism for the transmission of infection 
between hosts. These factors contribute to the high risk of epizootic disease in captive 
monkeys as confirmed by reported outbreaks of TB in rhesus macaque colonies
4,15,17
. 
 In order to prevent or control TB outbreaks, detection of infected individuals prior to 
their progression to clinical disease is vital. While the tuberculin skin test (TST) has 
long been used to detect mycobacterial infection in non-human primates (NHP), the 
sensitivity of this test has been questioned
3,5,9
 and these authors have suggested 
combining the TST with alternative immunological assays. 
Recently, it has been reported that a human diagnostic TB test, the QuantiFERON-TB 
Gold assay (In-Tube Method) (QFG-IT), appears valuable for the diagnosis of TB in 
chacma baboons (Papio ursinus)
11
. This test detects immunological sensitisation to the 
mycobacterial proteins early secretory antigenic target 6 kDa (ESAT-6), culture filtrate 
protein 10 kDa (CFP-10), and TB 7.7(p.4) by quantifying the secretion of IFN-γ by 
lymphocytes recognising these antigens
10
. The relative specificity of this test for M. 
tuberculosis and M. bovis is determined by the fact that the genes encoding these 
proteins have been deleted in the vaccine strain M. bovis Bacille Calmete-Guérin 
(BCG) and highly homologous genes encoding these proteins have been detected in 
only a limited number of nontuberculous mycobacteria including Mycobacterium 
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kansasii, Mycobacterium szulgai, and Mycobacterium marinum
1
. Immunological 
sensitivity to these latter organisms can therefore cause false positive results to the 
QFG-IT
1,19
 and it has been argued that other mycobacterial species may cause the same 
phenomenon
6
  
Following the detection of a TST-positive animal from a captive colony of rhesus 
macaques, we investigated the usefulness of a modified QFG-IT for the diagnosis of 
mycobacterial infection in this species.      
 
7.4 Materials and Methods 
7.4.1 Animals and housing 
Animals were housed outdoors in a coral and five group cages, and indoors, singly and 
in pairs, in galvanised wire mesh cages at the Delft Animal Facility of the Medical 
Research Council of South Africa in accordance with the revised South African 
National Standard for the Care and Use of Animals for Scientific Purposes (South 
African Bureau of Standards, SANS 10386). Permission to perform this study was 
obtained from the Committee for Experimental Animal Research of Stellenbosch 
University. Prior to TB testing and euthanasia, animals were tranquilised with 5 mg/kg 
ketamine hydrochloride (Kyron Laboratories, Benrose, South Africa).      
7.4.2 Tuberculin Skin Test 
Tuberculin Skin Tests were performed by intradermal injection of 0.1ml of bovine PPD 
(PPD
bov
) (WDT, Hoyerhagen, Germany) diluted in 0.9% saline to a final concentration 
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of 3000 IU/0.1 ml. The site of the TST was monitored daily for 72 hrs and any 
inflammatory response was scored as previously described
3
.  
7.4.3 QuantiFERON-TB Gold (In-Tube) Assay 
Blood sampling for the QFG-IT took place prior to the TST in 90/104 animals, three 
days after the TST in 13/104 animals, and both prior to and three days after the TST in 
a single animal (macaque No. 28). Three ml of blood was aspirated from the femoral 
vein of each animal via a 21G needle into a 5 ml syringe. Immediately, 1 ml aliquots of 
blood were transferred to a TB Antigen tube (containing ESAT-6, CFP-10 and TB7.7 
(p.4)), a Mitogen (positive control) tube (containing phytohaemagglutinin (PHA)), and 
a Nil (negative control) tube, respectively, of the QFG-IT system. Following vigorous 
shaking, blood collection tubes were maintained at room temperature until further 
processing. In agreement with others 
15
, we found PHA to be a poor stimulus for IFN-γ 
production in rhesus macaque blood (data not shown). Accordingly, using an insulin 
syringe, 0.1 ml of staphylococcal enterotoxin B (SEB) (Sigma-Aldrich, South Africa) 
diluted in RPMI 1640 (Sigma) was aseptically injected into the Mitogen tubes at a final 
concentration of 1 µg/ml as a positive control for IFN-γ production. All tubes were then 
incubated for 16-24 hrs at 37°C after which plasma fractions were aspirated following 
centrifugation (at 2500 x g) and stored at -20°C. 
Interferon-gamma concentrations in plasma samples, i.e. [IFN-γ]nil, [IFN-γ]tb and [IFN-
γ]mitogen, were determined in duplicate by enzyme-linked immunosorbant assay (ELISA) 
using a commercial kit according to the manufacturer’s instructions (Mabtech AB, 
Nacka Strand, Sweden, code: 3420M-1HP-10). The 95
th
 percentile of all [IFN-γ]nil 
values ([IFN-γ]nil95) was selected as a cut-off between non-specific background 
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responses and a positive assay result. Additionally, QFG-IT results were regarded as 
positive if [IFN-γ]tb-nil/[IFN-γ]nil > 0.25 (as recommended by the QFG-IT 
manufacturers). In one instance, a second QFG-IT was performed in a TST-
negative/QFG-IT-positive animal in order to confirm this result (i.e. macaque No. 28).  
7.4.4 Postmortem examination 
All animals which tested positive to either the TST or the QFG-IT assay were 
euthanised by intravenous injection of 200 mg/kg sodium pentobarbitone (Eutha-naze, 
Bayer Animal Health, Isando, South Africa). In addition, four animals in close contact 
with a confirmed TB case were euthanised as a biosecurity precaution. Carcases were 
subjected to complete postmortem examinations and tissue samples from all major 
organs, the tracheo-bronchial and ileo-caecal lymph nodes, and macroscopically 
diseased tissues were routinely prepared for histological examination and mycobacterial 
culture as previously described
12
. Mycobacterial speciation was performed by multiplex 
polymerase chain reaction (PCR)
18
 and 16S rRNA gene PCR sequencing 
7
. 
 
7.5 Results and Discussion 
7.5.1 Use of the QFG-IT in rhesus macaques 
For all animals, [IFN-γ]nil ranged from 0 – 873 pg/ml. Using box plot analysis, outliers 
in this range were excluded from the study as an unusually high [IFN-γ]nil value is 
recommended as an exclusion criterion by the the QFG-IT manufacturers. The 95
th
 
percentile of the modified [IFN-γ]nil range (0 – 179 pg/ml) was calculated as 155 pg/ml. 
Positive QFG-IT results were therefore defined as: [IFN-γ]tb > 155 pg/ml where     
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[IFN-γ]tb-nil / [IFN-γ]nil > 0.25. No specific cause for the high [IFN-γ]nil values was 
identified, however activation of leukocytes during syringe sampling and transfer of 
blood to the QuantiFERON tubes was suspected. Collection of blood directly into the 
QFG-IT collection tubes may mitigate this phenomenon. For all animals, [IFN-γ]mitogen  
was > 681 pg/ml.  
7.5.2 Detection of TB using the QFG-IT   
The identification of a TST-positive monkey (No. 12) during routine TB screening of 
the colony initiated this study. The QFG-IT performed on this individual three days 
after the TST resulted in a highly positive test result (Table 7.1). The animal was 
euthanised and a postmortem examination revealed multifocal to coalescing 
necrogranulomatous to pyogranulomatous inflammation of the left ventral lung lobe. 
The tracheo-bronchial lymph nodes were enlarged, firm, irregular, and on incision 
contained inspissated pus. The histopathology of affected tissues was typical of TB, 
consisting of multifocal lesions of caseous necrosis surrounded by macrophages, giant 
cells and lymphocytes with acid-fast organisms occasionally present. Mycobacterium 
tuberculosis was cultured from samples of these tissues. 
Four QFG-IT-negative and TST-negative animals in contact with this case (No. 11, 
P48, P60, and P92), euthanised as a biosecurity precaution, showed no gross pathology 
or histopathology, and all sampled tissues from these animals were negative for 
mycobacterial culture (Table 7.1). These findings confirm those of Parsons et al. (2009) 
that the QFT-IT shows promise as a useful tool for the diagnosis of TB in NHP. 
 
  
 
Table 7.1 Results of TST, QFG-IT (post-TST), postmortem examinations, and mycobacterial tissue cultures from rhesus macaques euthanised 
during this study. 
    QFG-IT (pg/ml)     
macaque TST [IFN]
tb 
 [IFN]
nil 
 [IFN]
tb-nil
 [IFN]
tb-nil
/[IFN]
nil
 Test Result Postmortem Speciation 
11 - 19 19 0 0 - nad - 
12 + 3120 84 3036 36 + pulmonary granulomas M. tuberculosis 
28 - 557 (246
a
) 40 (75
a
) 517 (171
a
) 12.9 (2.3
a
) + (+
a
) nad M. kansasii 
P48 - 32 32 0 0 - nad - 
P60 - 29 34 -5 -0.1 - nad - 
P92 - 22 35 -13 -0.4 - nad - 
-: negative; +: positive; nad: no abnormality detected 
a 
pre-TST results 
 
 
 
 
 
1
0
7
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7.5.3 Detection of M. kansasii infection using the QFG-IT 
A low positive QFG-IT result was obtained for a single TST-negative animal (macaque 
No. 28) (Table 7.1). A second QFG-IT performed on this animal 3 days following the 
TST gave a highly positive result (Table 7.1). This increased response was presumably 
due to boosting of existing immunological sensitivity to the test antigens following re-
exposure to these proteins in the PPD
bov
 as it has been shown that two-weekly TST and 
IGRA testing in rhesus macaques over a 12 week period did not sensitise healthy 
animals to PPD
bov 13
, and in the present study, no significant difference was detected in 
the QFG-IT responses between pre-TST and post-TST QFG-IT-negative monkeys (p = 
0.257) (e.g. Table 7.2). Such boosting of IFN-γ responses has been shown to occur, 
although less rapidly, in humans
14
 and the rapid onset of this effect observed in this 
monkey may be due to the composition of PPD
bov 
or the fact that a much greater PPD 
concentration is used in animal testing. 
 Postmortally, no evidence of gross pathology or histopathology was detected in this 
animal. However, M. kansasii was cultured from both a tracheo-bronchial lymph node 
and pooled samples of pulmonary and renal tissues. Together, the QFG-IT and tissue 
culture findings suggest true infection by this organism. Additionally, contamination of 
the samples during processing is unlikely as other tissues from this animal were culture 
negative as were samples from two other animals processed at the same time. Notably, 
M. kansasii is periodically cultured from TST-positive cattle
16
 and experimental M. 
kansasii infection in calves results in immunological sensitivity to recombinant ESAT-
6/CFP-10 protein in these animals
19
. More specifically, the QuantiFERON-TB Gold 
assay has been shown to be an effective tool for the diagnosis of M. kansasii disease in 
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humans
8
. Such findings are expected given the high degree of homology between 
ESAT-6 and CFP-10 proteins of M. kansasii, M. bovis
16
 and M. tuberculosis
2
.  
 
Table 7.2 Results of the QFG-IT for selected rhesus macaques tested either pre- or post-
TST 
 
QFG-IT 
 
macaque [IFN]
tb 
(pg/ml) [IFN]
nil 
(pg/ml) Test Result 
Pre-TST tested 
  P50 28 34 - 
P51 26 42 - 
P52 111 141 - 
P53 64 102 - 
P54 7 9 - 
Post-TST tested 
  9 115 130 - 
21 91 85 - 
25 17 25 - 
P47 6 11 - 
P82 20 20 - 
                      -: negative 
 
7.5.4 Summary 
This is the first report of the use of a modified QFG-IT for the diagnosis of 
mycobacterial infection in rhesus macaques and our findings provide further evidence 
that the QFG-IT is suitable for adaption for use in animals. This assay appears highly 
sensitive when used in rhesus macaques, detecting non-clinical infection by a mildly 
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virulent mycobacterium, M. kansasii. Hoever, this finding highlights the limitation of 
the QFG-IT assay to specifically detect M. tuberculosis or M. bovis infection and this 
must be considered when interpreting test results. A limitation of our study was the 
necessary use of an unvalidated cut-off point for defining test results. This limitation 
will remain a reality of NHP studies, complicated by the fact that validation of such 
parameters may require species-specific optimisation 
5
. However, in the absence of 
suitable cut-off data, our findings suggest that an observation of post-TST boosting of 
QFG-IT responses might be used to confirm test results. Additionally, performing the 
QFG-IT assay 3 days following a TST may increase its sensitivity and this protocol 
could be suitable for testing high-risk or quarantined animals. Despite the limitations 
identified, the QFG-IT has numerous benefits over other IFN-γ release assay formats 11, 
allowing initial processing of samples in moderately equipped laboratories and possibly 
even under field conditions. As such, our findings suggest that that this assay, modified 
as described here, could prove highly valuable in diagnosing and controlling 
mycobacterial infections in rhesus macaques and other species. 
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8.1 Introduction 
A number of incidents (both published and unpublished) regarding the unusual occurrence 
of tuberculosis (TB) and TB-like disease in animals in South Africa have emerged recently, 
highlighting infections caused by mycobacterial species. 
These incidents include reports on Mycobacterium goodii in a spotted hyaena
22
, M. xenopi 
in a ruffed lemur (unpublished), M. intracellulare in healthy wild-caught chacma baboons
1
, 
the so-called “dassie bacillus” in a free-ranging dassie16, as well as another dassie from the 
Western Cape (unpublished). In addition, reports on the “oryx bacillus” from an African 
buffalo in KZN (Gey van Pittius et al., manuscript submitted), M. bovis from a black 
rhinoceros belonging to the National Zoo
3
, M. tuberculosis in meerkats in the northern 
Cape (unpublished), M. tuberculosis in a domestic dog from Cape Town
15
, 2008), and M. 
tuberculosis in baboons
14
. None of these are necessarily surprising or alarming for a variety 
of reasons.  This communication is an attempt to put these in context. 
 
8.2 The Mycobacteria 
The genus Mycobacterium currently consists of 128 validly-published species and 5 
subspecies, of which some are fast growers and mostly non-pathogenic, while others are 
slow growers and usually pathogenic (J.P. Euzéby: List of Prokaryotic names with 
Standing in Nomenclature (LPSN) - http://www.bacterio.cict.fr/). This latter branch 
includes those in the M. tuberculosis complex (MTC), such as M. canettii, M. tuberculosis, 
M. africanum (subtype Ia and Ib), dassie bacillus, oryx bacillus, M. microti (the vole 
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bacillus), M. pinnipedii (the seal bacillus), M. caprae (the goat bacillus), M. bovis (the 
bovine bacillus) and M. bovis BCG, (see Fig 8.1)
7
. Those mycobacterial species that are not 
usually pathogenic may become pathogens under unusual circumstances.  In humans, these 
circumstances may include HIV infection, diabetes and steroid treatment, which suppresses 
the immune system and can allow usually non-pathogenic organisms to become 
pathogens
17
.  
The mycobacteria are regarded as very successful organisms and occupy a wide range of 
niches in the environment (soil and water) as well as being obligate pathogens in some 
cases
13
.  Some mycobacterial species have even been found to colonize extremely harsh 
environments, such as extreme acidity (pH 3.0) and temperature (56ºC) in acidic hot 
springs in Yellowstone National Park
19
. In fact, 37% of gene clones analysed from a highly 
acidic (pH 1.0) volcanic environment were found to originate from previously unidentified 
mycobacterial species
23
, signifying their ability to survive under extreme conditions. New 
species of mycobacteria are constantly being identified (9 new species were described in 
2006 alone) and 52% of known species have been identified in the last 20 years (data not 
shown). We have recently found at least 5 new species from human sampling in the 
Western Cape in South Africa, which we are in the process of characterizing (NC Gey van 
Pittius, personal communication). 
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Fig. 8.1 Phylogenetic tree of the members of the Mycobacterium tuberculosis complex. 
“RD” denotes specific “regions of difference” detected between the genomes of different 
species. 
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The mycobacteria that are able to colonize animals have evolved such that many specialise, 
forming host-adapted ecotypes with preferred hosts
20
. These include M. tuberculosis and 
M. africanum, which tend to be found almost exclusively in humans. M bovis, on the other 
hand, has a very broad range of hosts, although it is found primarily in bovids.  It is 
interesting to note that although many of these species (that are pathogenic to mammals) 
have evolved from a common ancestor (see fig 1), they are rarely, under natural 
circumstances, found outside of a defined host or host family (e.g. M. microti in voles, M. 
pinnipedii in seals, and dassie bacillus in dassies).  In addition, there is strong evidence for 
an original home range or home population for some species or subspecies
20
. It should be 
noted that even M. tuberculosis has evolved extensively, leading to various strains and 
substrains that have individual differentiating characteristics.  Some strain types are seen in 
abundance in certain populations of people or geographical regions and are absent or 
almost absent in other regions. Accordingly, we have the well-known “Beijing” strains of 
M. tuberculosis that are highly abundant in Asia and have now spread worldwide.  This 
strain family is highly successful
6,21
, prone to becoming drug resistant
8
 (Johnson et al., 
manuscript in preparation), and is increasing in numbers in the Western Cape relative to 
other strains
21
.  On the other hand, the so-called KZN (XDR) TB strain, which caused 
much publicity recently with high numbers of deaths in Tugela ferry
4
, is not a new strain at 
all, but is part of a family of M. tuberculosis strains found all over South Africa
21
. This 
XDR strain variant of M. tuberculosis has found a vulnerable population in an extremely 
high HIV incidence area and has thus been able to cause increased mortality in this 
population
4
.   
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8.3 New technologies highlight emerging disease 
While many basic microbiological techniques to define mycobacterial species were 
developed decades ago, these are extremely labour intensive and cannot discriminate all 
species or subspecies and certainly not strain types. However, these techniques were able to 
define important pathogens such as M. tuberculosis and M. bovis in the late 1800’s and 
even less important ones such as the dassie bacillus in the late 1950s.  The dassie bacillus 
(which has never received a “proper” name), was found first in dassies from the Nieu 
Bethesda area, was tested for virulence by deliberate infection in a number of TB 
susceptible animal species and found to be non-pathogenic in these.   
However, newly developed molecular-based (genome) techniques allow one to develop 
entirely new diagnostic and typing techniques and to identify species and subspecies more 
easily and more accurately. Such technologies, which include PCR-sequencing of target 
genes, as well as line probe hybridization assays, have been successfully applied to the 
mycobacterial field.  These are usually based on detection of known specific DNA 
sequences, and include the newly-developed Hain Genotype product series which is used to 
speciate some Mycobacteria and to detect certain drug resistance markers
18
. These easy to 
use, fast and accurate techniques have allowed an explosion of new investigations, aimed at 
re-examining many of the old established dogmas in mycobacterial disease.  A vast body of 
this type of work is done in research-based laboratories, where traditionally, research 
results often do not reach a wider audience.  This paradigm is shifting, with researchers 
now putting more effort into translational research and dissemination of information.  
Some effort has also been directed to check that past species identification is in fact correct.  
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This was not possible in the past because of old and crude techniques which were not 
adequately discriminatory or simply too labour intensive and expensive to utilise.  
 It should be noted that with the advent of antibiotics (mostly from the late 1950s up to the 
mid-1960s), TB incidences largely stabilised or declined in the human population in many 
countries
10
.  Similarly, in the veterinary field, prevalence of M. bovis declined, since skin 
testing and slaughter policies were quite effective
11
. The consequence was that TB was 
thought to be conquered and it became a neglected area of research for quite some time.  
This is nowhere clearer illustrated than in the words of the Nobel prize winner Selman A. 
Waksman (discoverer of over twenty antibiotics) who in 1964 said in his “The Conquest of 
Tuberculosis” that “…the ancient foe of man, known as consumption, the great white 
plague, tuberculosis, or by whatever other name, is on the way to being reduced to a minor 
ailment of man.  The future appears bright indeed, and the complete eradication of the 
disease is in sight…” 
 
8.4 The “new” TB epidemic 
For reasons that are not clear, the incidence of M. tuberculosis in the South African 
population increased dramatically from the mid-1970s even prior to the introduction of 
HIV (South African National Department of Health). Similar increases were noted 
worldwide, even in developed countries such as the USA where socio-economic conditions 
were good and healthcare was improving steadily. This prompted new investment and a 
resurgence of research in TB, with the additional development of new technology.  
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Using these new sensitive tools, we are now able to find new mycobacterial species in 
previously unidentified niches. It is likely that many of these were present in the past, but 
simply not identified or misidentified using the crude techniques of the past.  Essentially, 
we find them because we are now actively looking for them and because recent research 
has allowed more detailed speciation. We have identified a number of these rare species in 
our laboratory at Stellenbosch University, but this is part of our advanced research 
programme and one should not expect such sophistication from a routine diagnostic lab.  
We recently embarked on a large TB prevalence survey in humans in the Western Cape 
and while we found many individuals with M. tuberculosis infection who were 
asymptomatic, as expected, we found essentially as many who were infected by non-
tuberculous mycobacteria (unpublished). Some of these mycobacteria are known 
pathogens, but no apparent signs of clinical disease were evident in the individuals infected 
by them. We do not know the impact of these infections and this will require extensive 
research to try to understand. Some of these individuals were followed up to ascertain if 
disease developed, but no symptoms are yet evident in those checked (unpublished results). 
Additionally, because of “failure to cure”, we have diagnosed M. intracellulare in two 
human cases recently (unpublished data). If these samples had not been sent to our research 
laboratory, they would have been classified as drug resistant TB and treated accordingly, or 
the patient may have died, as the case may be.  Both patients were of advanced age, with 
the indication therefore that M. intracellulare may primarily be a pathogen of 
immunocompromised individuals. 
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8.5 Relevance to animals 
The “new or emergent” TB in animals should be seen in a similar light. There have been 
many cases of cross-species infection from zoos. The most common perhaps is M. 
tuberculosis moving into animals from handlers or the viewing public
12
, or M. bovis 
moving between animals or to human handlers from the animal. We have found M. 
tuberculosis in captive baboons
14
) and vervet monkeys in South Africa and even in free 
living baboons in close contact with farm workers or farmyards. This is not at all 
surprising, given the cavalier attitude to TB evinced by many South Africans, with spitting 
and unsanitary behaviour being common, and a TB incidence rate which is arguably the 
highest in the world. 
We were aware of the dassie bacillus which has more recently been isolated in Australia 
from captive dassies originating from the RSA
2
.  We were therefore keen to obtain a dassie 
carcass that showed visible lesions to see if we could “rediscover” this species in South 
Africa, since we were not able to obtain a culture from outside the RSA for our basic 
research.  This opportunity occurred recently when 2 apparently healthy dassies in good 
condition were shot as part of a leopard research project in the Winterhoek Mountains of 
the Western Cape. The dassie had extensive necrogranulomatous pneumonia due to 
infection with the dassie bacillus
16
. Since previous reports of the dassie bacillus do not 
point to the Western Cape, this most likely shows that the dassie bacillus is wide-spread in 
the RSA. However, this should be confirmed, since we do not have final proof of its 
distribution.  
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We recently diagnosed a case of M. bovis infection in a black rhinoceros held in one of the 
facilities of the National Zoological Gardens
3
.  In the case of this rhino, it should be noted 
that the rhinoceros was elderly and in poor condition. It cannot be said unequivocally that 
M. bovis caused the poor condition of the rhinoceros at all, since only two relatively small 
lesions were found at necropsy.  
It is perhaps pertinent to note at this point that tuberculosis in humans is a complex disease. 
We know that after infection three possible routes can be taken: 1) the person does not 
establish an infection at all and the bacteria are killed, 2) a primary infection is established, 
but contained and no symptoms occur, 3) there is immediate progression to disease. In the 
absence of immunosuppression, only 5% of infected individuals fall into the latter class. Of 
those who initially contain infection, only 5% develop disease in their lifetime. In 
developed countries such as Europe and the USA, one can see this phenomenon in the 
elderly, once the immune system functionality declines. Thus, fewer than 10% of infected 
humans will develop active TB after infection (in the absence of immunosuppression).  
We do not know what the situation is in different animal species, or whether different 
mycobacteria can do the same as M. tuberculosis in humans. However, it is highly likely 
that a similar situation prevails in many animals with perhaps quantitative differences in 
their relative proportions that progress to active disease soon after infection compared to 
those which can be latently infected and reactivate later.  
Thus we speculatively explain the recent “oryx bacillus” event in which an oryx bacillus 
was isolated from a healthy, skin test positive African buffalo on a farm known to have 
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previously imported buffalo from a zoo in Portugal (Gey van Pittius et al., manuscript in 
preparation).  The oryx bacillus was originally isolated from Arabian oryx and camelids, 
and thus far appeared to be restricted to the northern hemisphere. Buffalo captive in a 
Portuguese zoo were probably in contact with Arabian oryx, which allowed infection.  The 
oryx bacillus infection was presumably kept in check by the innate or adaptive immune 
system of the buffalo. Some buffalos from the Zoo in Portugal were then transferred to 
South Africa approximately 20 years ago, in all likelihood bringing the dormant oryx 
bacillus in at least one animal. It is unlikely that we have sampled such an animal, but 
transmission between animals without observed symptoms might have occurred and we 
detect it in a second or third generation animal. Given the rare reactions seen in this herd, 
as well as the lack or apparent lack of disease noted over nearly 20 years, as far as our 
information extends, it is likely that this is not a serious pathogen in buffalo. However, we 
do not know that for certain, and we also do not know what could happen if it were to be 
excreted by the buffalo and infect other wildlife.  The pathogenicity of the organism in the 
Southern African oryx species called the Gemsbok (Oryx gazella) has never been 
established, but given their relatedness to the Arabian oryx, the preferred host species of 
this organism, it can be hypothesized that it would also be pathogenic for gemsbok.  
Perhaps the oryx bacillus (like the dassie bacillus) is less virulent than M. tuberculosis or 
M. bovis. (Virulence is not understood at all well in mycobacteria, particularly when the 
species is not in its preferred host).  Buffalo may even have reasonable innate resistance to 
oryx bacillus, although clearly not to M. bovis. Note that M. tuberculosis infection is 
extremely rare in bovids and that transfer of M. tuberculosis from one bovid to another is 
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not a problem in infected bovids, as far as we know. We should not lose sight of the fact 
that M. bovis is probably a far more serious mycobacterial pathogen compared to the oryx 
bacillus, however.  We do not even know whether buffalo infected by the oryx bacillus will 
mount a positive skin test response in all cases. The only way to know is to test this 
experimentally.  
From a management point of view, this is a difficult problem. One cannot know whether 
the oryx bacillus has crossed into another host with potential to infect buffalo again. 
Therefore to slaughter all buffalo on the affected property may not work. On the other 
hand, a typical response to a BTB herd would be recommended, i.e. initial test and 
slaughter, with regular follow up if possible.  
Finally, it should be noted that in many instances, cases of TB in animals do not involve 
the lungs and therefore unless the animal is eaten uncooked (e.g. predated), it presents only 
a remote chance for transmission, particularly to humans. 
 
8.6 Dog TB 
In a recent case
15
, a stray Maltese crossbreed domestic dog with extensive multifocal 
pulmonary tuberculosis due to M. tuberculosis was detected as part of an intensive research 
project being done in our centre to investigate innate resistance to TB. The rationale is that 
if we can understand innate or acquired resistance, we may be able to develop entirely new 
therapies. Since TB has been reported very rarely in dogs, we hypothesize that dogs have 
innate resistance to TB. In order to do this study, we selected dogs which would come from 
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communities in Cape Town that have amongst the highest reported TB incidence in the 
world. We know that at least 80% of adults in these communities show infection by M. 
tuberculosis (exposure)
9
 and therefore the dogs are almost certainly also exposed to TB 
infection. Owing to poverty and many other social factors, hundreds of dogs from such 
communities are euthanized by animal welfare organisations every year and these animals 
provide an important resource for biosurveillance of zoonotic diseases such as TB. A 
limited post mortem survey of 100 stray dogs, using the “gold standard” of diagnosis, viz., 
culture, detected 1 animal with pulmonary tuberculosis, and infection in 3 others which 
showed no gross or histopathological signs of disease. Apart from bacterial culture, there is 
no validated test for TB infection in dogs; however, we have detected a high prevalence of 
immunological sensitivity to M. tuberculosis antigens among dogs living with TB patients 
suggesting a high level of transmission of this pathogen from owners to their pets. Our 
interpretation of these early findings is that despite frequent transmission of M. 
tuberculosis to dogs, a relatively small number of infected animals progress to active TB 
and that these animals contribute negligibly to the national TB epidemic. As such, our 
current data suggests no need for a concerted intervention in this regard. 
However, there may be particular circumstances where the potential for pets to act as 
reservoirs of infection should be carefully considered. HIV positive individuals are highly 
susceptible to TB and, where possible, companion animals living in close contact with 
immunocompromised individuals should be screened for all zoonotic diseases. Animals 
that have potentially been infected by multi drug-resistant (MDR) strains of M. 
tuberculosis warrant concern. The management of MDR-TB requires enormous resources 
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and in extreme cases, this disease may be virtually untreatable. Companion animals 
infected with these strains therefore potentially pose a significant danger to human health. 
However, since we have found only one case of TB with fulminating lesions in a dog after 
3 years of working in a high risk environment, transmission of TB from dogs can be 
regarded to be highly unlikely in most cases. Given the infection pressure of M. 
tuberculosis from human to human, particularly in South Africa where the disease is so 
prevalent, dog-to-human transmission risk is almost certainly therefore vanishingly low.  
However, it may be of interest to practising vets, who may suspect TB occasionally in a 
dog or related wild animal.  In our opinion, it does not justify any intervention strategies at 
this stage.  
 
8.7 Why did we not find these before? 
It should be noted that new technology, particularly in genomics, has made identification 
easier and more accurate, and more mycobacterial species are differentiated and described 
every year. Mycobacteria are common in the environment
11
 and under the right 
circumstances can become pathogens. We may therefore expect more, but probably rare, 
interesting and unusual cases to emerge over time.  
It is estimated that there are approximately four to six nonillion (4-6 x 10
30
) bacteria on 
Earth
25
, and that we have only described around 4000 prokaryotic species to date, with 
recent estimates for the number of species in this domain of life ranging from 10
5
 to 10
75
 
Clearly, identification and description of these is beyond the remit and capabilities of 
127 
 
routine laboratories. It is also costly to establish advanced technology, particularly for rare 
events, and therefore not within the boundaries of most routine investigations. Most 
practising clinicians and veterinarians cannot be expected to be aware of the complexities 
of the Mycobacteria as a genus, nor of what might constitute an appropriate request for an 
advanced level test nor appropriate response to an unusual result.  This is still a highly 
specialised research area. Our laboratory has developed a very deep and thorough 
speciation technology
24,22
 involving genomics and bioinformatics. As such, we do not offer 
a routine diagnostic service, but a research based collaborative service. We deliberately 
search for interesting cases and mycobacterial species as part of our interest and mandate. 
Even this has only very recently been made possible by increased funding and new 
technologies that we have developed.  
 
8.8 Conclusion 
Much research still needs to be done to understand TB in humans and animals. Vigilance 
needs to be exercised, but not at the cost of trying to keep in check the major epidemics of 
M. tuberculosis in humans in SA, and M. bovis in domestic stock and wildlife. We are 
increasingly finding cases of TB-like disease due to species of mycobacteria not within the 
M. tuberculosis complex, but this may simply represent our success in searching 
deliberately for these. Many of these were almost certainly here before recent reports, but 
remained undetected because of rare occurrence, or the absence of clinical disease and of 
tools or funding to identify them. At this stage, in our opinion, it is doubtful that they 
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represent a serious threat to animal or human health other than at an occasional individual 
level. Nevertheless, many of the Mycobacteria can be regarded as “alien” to the RSA and 
as such should be kept under surveillance. Any veterinarian or biologist who finds an 
“unusual” case that is a suspect mycobacterium sp. infection is most welcome to contact us 
in this regard.  
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_______________________________________________ 
CHAPTER 9 
Conclusion 
______________________________________________________________________ 
 
Comparative studies have long contributed to the understanding of the aetiology, 
pathogenesis, and diagnosis of tuberculosis (TB). With this in mind, opportunities to 
investigate naturally occurring mycobacterial infections in animals were identified in 
order to gain further insight into this disease. During the course of this study, the dassie 
bacillus, an unusual member of the Mycobacterium tuberculosis complex (MTC), was 
isolated from a free-living rock hyrax; the occurrence, epidemiology and immunology 
of canine M. tuberculosis infection was studied; and a novel method for the diagnosis of 
TB in non-human primates was investigated. Additionally, the documentation of 
unusual mycobacterial infections in various animals in South Africa was reviewed.      
The identification and documentation of the occurrence of the dassie bacillus in a 
population of rock hyraxes in the Western Cape provides impetus and opportunity to 
further investigate this pathogen. Prior to this finding, the dassie bacillus had been 
isolated in the late 1950s from rock hyraxes from Nieu-Bethesda in the Eastern Cape 
Province of South Africa and from zoo specimens captured at unknown sites in this 
country. Our finding therefore suggests that this bacillus is widespread in the South 
African rock hyrax population. Subsequently, Gudan et al. (2008) have reported the 
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isolation of M. africanum from a rock hyrax originating from the United Arab Emirates 
(UAE)
4
. The authors used a commercial speciation assay, the GenoType MTBC (Hain 
Lifescience GmbH, Nehren, Germany) which uses DNA sequence polymorphisms of 
the gene DNA gyrase subunit B (gyrB) to differentiate between members of the MTC
6
. 
However, criteria for the speciation of the dassie bacillus are not included in this test. 
Given that the dassie bacillus and M. africanum share common single nucleotide 
polymorphisms (SNPs) in gyrB, and that M. africanum has been almost exclusively 
isolated in West Africa and only occasionally elsewhere
5
, it seems highly probable that 
the organism isolated from the UAE rock hyrax was in fact the dassie bacillus, 
suggesting that this bacillus is more widespread than previously documented. 
Unfortunately, following initial growth of this bacillus in our laboratory, stocks thereof 
stored both at - 80°C and at 37°C could not be re-cultured for further analysis. 
However, our identification of this organism in local rock hyrax populations presents 
the possibility of actively attempting to re-establish such cultures. The dassie bacillus 
displays limited virulence in many laboratory animals which are susceptible to M. 
tuberculosis and M. bovis
7
 and comparative genetic studies of these organisms could 
reveal genetic traits which confer such virulence. While known virulence factors (i.e. 
ESAT-6 and CFP-10) are encoded by the genetic region of difference 1 (RD1) of the 
MTC genome
2
, M. microti, M. bovis BCG and the dassie bacillus all contain large 
sequence polymorphisms (LSP) in this region. The variation in virulence of these 
mycobacteria
7
 therefore suggests that other important virulence factors may be 
identified through comparative studies of these organisms. 
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Vaccination of guinea pigs with the dassie bacillus has been shown to confer partial 
immunity to M. bovis infection, almost doubling their time to death following infection 
with M. bovis
7
. This is similar to the protection conferred by M. bovis BCG vaccination 
which reduces time to death in guinea-pigs following M. tuberculosis infection
3
. It has 
been suggested that only an effective vaccine program will control or eliminate TB
1
. It 
is therefore tempting to consider whether the dassie bacillus would not be a suitable 
candidate for development as an alternative TB vaccine, especially in ecosystems in 
which the bacillus naturally occurs, for example in African wildlife. 
An investigation of the virulence of the dassie bacillus in rock hyraxes may also prove 
valuable. It has been reported that in recent years there has been a sharp decline in rock 
hyrax populations in some regions of South Africa (pers. com. P.D. van Helden). The 
cause for this is unknown, but the finding of severe TB in a free-living rock hyrax 
suggests that a study of the impact of this disease on the population dynamics of this 
species may be warranted.     
The investigation of the spillover of M. tuberculosis from human TB patients to contact 
dogs provided an opportunity to explore the occurrence, epidemiology, and 
immunology of TB in this species. As a result of this study, the first known example of 
this disease in South Africa was recorded. Additionally, in the particular social setting 
in which this study was performed, high levels of M. tuberculosis transmission were 
shown to occur between smear positive TB patients and their pet dogs, even when 
interaction between humans and pets was not particularly close. A potential danger of 
canine tuberculosis is the fact that diseased animals could act as a source of human 
infection and early detection of these animals may be important. However, no 
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immunological tests have been validated for the diagnosis of canine TB and 
development of such tests would prove highly valuable. In this regard, ElephantTB 
STAT-PAK, a serological test for TB has shown some promise (pers. com. M. L. 
Boschiroli), however, validation of this or other tests will require further studies.  
Despite the documentation of high levels of M. tuberculosis transmission to companion 
dogs, the rarity with which canine TB is diagnosed during human TB epidemics 
supports experimental data that this species is naturally resistant to this disease. As 
such, an attempt was made to further characterise the cell-mediated responses to TB in 
infected dogs, thereby potentially identifying markers of such resistance. Such an 
undertaking had three major limitations. Firstly, no validated assay was available for the 
identification of truly infected animals. Nonetheless, immunological sensitivity to the 
proteins ESAT-6 and CFP-10, both reasonably specific to the MTC, might have 
provided a suitable proxy for a definitive diagnosis. A second limitation was the limited 
availability of suitable canine reagents, meaning that convoluted and time-consuming 
techniques had to be employed to suitably label peripheral blood mononuclear cells 
(PBMC) for analysis by flow cytometry. Thirdly, the differences in the biology of 
canine immune cells compared to other species precluded the planned use of 
lymphoproliferative assays used to investigate the CMI of TB in humans and a number 
of ruminant species. While the availability of species-specific and cross-reactive 
reagents will improve, the infection status of animals naturally exposed to TB will often 
remain unverified, and unpredictable biological differences between species will 
continue to hamper the investigation of TB immunology in non-experimental and 
poorly characterised species.  
135 
 
The diagnosis of TB in such species may, however, benefit from the modification of a 
commercial human TB interferon-gamma release assay (IGRA). We have shown that 
the use of the QuantiFERON-TB Gold (In Tube Method) assay (QFG-IT) shows great 
promise as a sensitive test for TB in baboons, and that a modification of this assay was 
able to detect both active TB and non-clinical mycobacterial infection in a rhesus 
macaque. Because the QFG-IT is performed in closed test tubes containing the test 
antigens, processing and incubation of samples does not require sterile conditions, 
making the test suitable for veterinary applications. As such, further investigation of the 
use of this modified test in other species may prove valuable. 
Together, these studies have systematically investigated natural mycobacterial infection 
in various species in South Africa, identifying the possibilities and limitations of such 
studies to provide insights into TB pathogenesis, epidemiology, and diagnosis.   
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